Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Germany
Clinical trial register · Germany

Clinical Trials in Germany

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2869
Recruiting now
open to new participants
983
Lead sponsors
across recruiting studies
Top sites
Berlin 1587 Hamburg 893 Essen 765 Dresden 714 Heidelberg 626
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca188 Novartis Pharmaceuticals142 Hoffmann-La Roche99 Merck Sharp & Dohme LLC98 Eli Lilly and Company98 Charite University, Berlin, Germany95 Janssen Research & Development, LLC90 University Hospital Tuebingen85 AbbVie79 Universitätsklinikum Hamburg-Eppendorf78 Bristol-Myers Squibb67 Sanofi65 Boehringer Ingelheim60 Pfizer56 University Hospital Heidelberg52 GlaxoSmithKline49 Novo Nordisk A/S49 Amgen49 University of Erlangen-Nürnberg Medical School47 Technical University of Munich46 Heinrich-Heine University, Duesseldorf45 Technische Universität Dresden44 Takeda31 Bayer31 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest28 University of Ulm28 Regeneron Pharmaceuticals26 Abbott Medical Devices26 Incyte Corporation26 University of Cologne25 University Hospital, Essen25 Ludwig-Maximilians - University of Munich24 Hannover Medical School24 University of Leipzig24 argenx23 Wuerzburg University Hospital23 University Hospital, Bonn23 University Hospital Schleswig-Holstein22 Boston Scientific Corporation22 Gilead Sciences22 European Organisation for Research and Treatment of Cancer - EORTC21 Daiichi Sankyo21 University Hospital Muenster20 Universität Münster19 Jena University Hospital19 University Hospital, Basel, Switzerland19 University Medical Center Goettingen18 Celgene18 LMU Klinikum18 Vertex Pharmaceuticals Incorporated17 iOMEDICO AG17 Insel Gruppe AG, University Hospital Bern17 University of Giessen17 Aesculap AG17 Alexion Pharmaceuticals, Inc.17 UCB Biopharma SRL16 Goethe University16 BeOne Medicines16 Johannes Gutenberg University Mainz16 University Hospital Freiburg16 Genmab15 University Medicine Greifswald15 RWTH Aachen University15 Biogen15 Heidelberg University15 Universität des Saarlandes14 German Cancer Research Center14 University Hospital Augsburg14 Ipsen14 Universität Duisburg-Essen13 BioNTech SE13 University of Bonn13 Edwards Lifesciences12 Alnylam Pharmaceuticals12 AO Innovation Translation Center11 Central Institute of Mental Health, Mannheim11 BioMarin Pharmaceutical11 Exelixis11 Deutsches Herzzentrum Muenchen10 Zimmer Biomet10 Astellas Pharma Global Development, Inc.10 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company10 W.L.Gore & Associates10 Ionis Pharmaceuticals, Inc.9 University of Luebeck9 AIO-Studien-gGmbH9 University Hospital of Cologne9 Philipps University Marburg9 EMD Serono Research & Development Institute, Inc.9 Seagen, a wholly owned subsidiary of Pfizer8 University of Regensburg8 German Diabetes Center8 Genentech, Inc.8 Stichting Hemato-Oncologie voor Volwassenen Nederland8 Women's Cancer Study Group GmbH8 MedSIR7 Leipzig Heart Science gGmbH7 University of Kiel7 German CLL Study Group7 Philogen S.p.A.7 Institut de Recherches Internationales Servier7 University of Wuerzburg7 Sarepta Therapeutics, Inc.7 Medical University of Vienna7 Medtronic Cardiovascular7 Miltenyi Biomedicine GmbH7 BDH-Klinik Hessisch Oldendorf7 ViiV Healthcare7 Kite, A Gilead Company6 Biotronik AG6 Prof. Dr. med. Ingo Eitel6 Alfasigma S.p.A.6 Immunovant Sciences GmbH6 IHF GmbH - Institut für Herzinfarktforschung6 Biotronik SE & Co. KG6 Revolution Medicines, Inc.6 Jazz Pharmaceuticals6 Research Center Borstel6 Agios Pharmaceuticals, Inc.6 Xenon Pharmaceuticals Inc.6 Mirum Pharmaceuticals, Inc.6 German Institute of Human Nutrition6 JOTEC GmbH6 Medical University Innsbruck6 Taiho Oncology, Inc.6 Loxo Oncology, Inc.6 CSL Behring6 Acerta Pharma BV6 University of Oxford5 Erasmus Medical Center5 Population Health Research Institute5 MED-EL Elektromedizinische Geräte GmbH5 Johann Wolfgang Goethe University Hospital5 Celldex Therapeutics5 Vascutek Ltd.5 Octapharma5 Medtronic5 University Medical Center Groningen5 Mirati Therapeutics Inc.5 European Myeloma Network B.V.5 Max-Planck-Institute of Psychiatry5 Lifetech Scientific (Shenzhen) Co., Ltd.5 Swedish Orphan Biovitrum5 Nationwide Children's Hospital5 University of Pennsylvania5 Fresenius Medical Care Deutschland GmbH5 Abiomed Inc.5 Institut fuer Frauengesundheit5 Blueprint Medicines Corporation5 Princess Maxima Center for Pediatric Oncology5 Medtronic Vascular5 Amsterdam UMC, location VUmc5 Institut für Pharmakologie und Präventive Medizin5 CatalYm GmbH5 M.A. Med Alliance S.A.5 Chiesi Farmaceutici S.p.A.5 Asklepios proresearch5 Christian Buske5 LEO Pharma5 Genzyme, a Sanofi Company5 Ultragenyx Pharmaceutical Inc5 Washington University School of Medicine5 Otsuka Pharmaceutical Development & Commercialization, Inc.5 Universitaire Ziekenhuizen KU Leuven4 Philips Clinical & Medical Affairs Global4 Eisai Inc.4 JCR Pharmaceuticals Co., Ltd.4 University Hospital Goettingen4 Weill Medical College of Cornell University4 Intellia Therapeutics4 Aragon Pharmaceuticals, Inc.4 University College, London4 Vir Biotechnology, Inc.4 Heart and Diabetes Center North-Rhine Westfalia4 Crinetics Pharmaceuticals Inc.4 Intuitive Surgical4 Zenas BioPharma (USA), LLC4 Occlutech International AB4 Pierre Fabre Medicament4 Stemline Therapeutics, Inc.4 Klinik für Kardiologie, Pneumologie und Angiologie4 Friedrich-Alexander-Universität Erlangen-Nürnberg4 Janssen Pharmaceutica N.V., Belgium4 Medical University of Graz4 Jaeb Center for Health Research4 Gaia AG4 Segeberger Kliniken GmbH4 University of Heidelberg Medical Center4 Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)4 University of Freiburg4 Immunocore Ltd4 Ruhr University of Bochum4 University of Zurich4 RECORDATI GROUP4 Martini-Klinik am UKE GmbH4 Amicus Therapeutics4 UMC Utrecht4 Italfarmaco4 Medtronic Cardiac Ablation Solutions4 Biosense Webster, Inc.4 St. Josefs-Hospital Wiesbaden GmbH4 Jasper Gerritsen4 BioInvent International AB4 Karyopharm Therapeutics Inc4 Acandis GmbH4 Heart Center Leipzig - University Hospital4 Kliniken Essen-Mitte4 Deciphera Pharmaceuticals, LLC4 Leiden University Medical Center4 GBG Forschungs GmbH4 IDEAYA Biosciences4 Cardioangiologisches Centrum Bethanien4 Teva Branded Pharmaceutical Products R&D LLC4 University Hospital, Geneva4 North Eastern German Society of Gynaecological Oncology4 Société des Produits Nestlé (SPN)4 Max Planck Social Neuroscience Lab4 Syndax Pharmaceuticals4 Juergen Debus3 Insmed Incorporated3 German Heart Institute3 Helmholtz Zentrum München3 LeMaitre Vascular3 Assistance Publique - Hôpitaux de Paris3 EyePoint Pharmaceuticals, Inc.3 University of Göttingen3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3 Camurus AB3 Cardiovalve Ltd.3 BioCryst Pharmaceuticals3 Evangelical Hospital Düsseldorf3 Cytokinetics3 Azafaros B.V.3 Summit Therapeutics3 Radboud University Medical Center3 Avidity Biosciences, Inc.3 Fraunhofer-Institute of Toxicology and Experimental Medicine3 Klinikum-Fuerth3 Nuvalent Inc.3 Avalyn Pharma Inc.3 Sanofi Pasteur, a Sanofi Company3 Max Planck Institute for Human Cognitive and Brain Sciences3 Corcept Therapeutics3 University Medical Center Mainz3 Implantica CE Reflux Ltd.3 HighLife SAS3 University of Aarhus3 Prof. Wolfgang Janni3 Kymera Therapeutics, Inc.3 Bielefeld University3 Pharvaris Netherlands B.V.3 IRCCS San Raffaele3 Penumbra Inc.3 IntraBio Inc3 Biosensors Europe SA3 Artcline GmbH3 Cullinan Therapeutics Inc.3 iVascular S.L.U.3 Ascentage Pharma Group Inc.3 Kura Oncology, Inc.3 MoonLake Immunotherapeutics AG3 AOP Orphan Pharmaceuticals AG3 DePuy Orthopaedics3 University of Witten/Herdecke3 ReCor Medical, Inc.3 Tesaro, Inc.3 Travere Therapeutics, Inc.3 The Lymphoma Academic Research Organisation3 Dominik Paul Modest3 Longboard Pharmaceuticals3 Denali Therapeutics Inc.3 West German Center of Diabetes and Health3 Janssen-Cilag Ltd.3 iSTAR Medical3 Center for Epidemiology and Health Research, Germany3 AGO Research GmbH3 Helios Health Institute GmbH3 Abivax S.A.3 Zealand Pharma3 CVRx, Inc.3 Ad scientiam3 Medtronic Cardiac Surgery3 Replimune, Inc.3 Arrowhead Pharmaceuticals3 University of Jena3 Galderma R&D3 Euresist Network GEIE3 Dr. Inge Winter3 Actelion3 ADARx Pharmaceuticals, Inc.3 Eikon Therapeutics3 Viatris Innovation GmbH3 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3 Institut National de la Santé Et de la Recherche Médicale, France3 Istituto Giannina Gaslini3 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Dentsply Sirona Implants and Consumables3 Inari Medical3 United Therapeutics3 European Breast Cancer Research Association of Surgical Trialists3 A.M.I. Agency for Medical Innovations GmbH3 Cogent Biosciences, Inc.3 Xenios AG3 MicroPort Orthopedics Inc.3 Viridian Therapeutics, Inc.3 Astria Therapeutics, Inc.3 Okuvision GmbH3 Heart and Brain Research Group, Germany3 Copenhagen University Hospital, Rigshospitalet3 IO Biotech2 dsm-firmenich Switzerland AG2 medac GmbH2 NEC Bio B.V2 University Hospital, Antwerp2 C. R. Bard2 Albireo, an Ipsen Company2 CoreAalst BV2 Kartos Therapeutics, Inc.2 Ethicon, Inc.2 Region Skane2 Genetix Biotherapeutics Inc.2 Rigel Pharmaceuticals2 OrbusNeich2 Krankenhaus Nordwest2 Odense University Hospital2 Michael Hopp2 Biotech Healthcare Holding Gmbh2 Fondation Hôpital Saint-Joseph2 Upstream Bio Inc.2 Arcus Biosciences, Inc.2 Atrial Fibrillation Network2 Amber Implants B.V.2 Debiopharm International SA2 German Federal Institute for Risk Assessment2 Nyxoah S.A.2 Advanced Bionics AG2 Schön Klinik Berchtesgadener Land2 Cardiovascular and Interventional Radiological Society of Europe2 Simon Jäger2 Herzzentrum Bremen2 Omeros Corporation2 Akero Therapeutics, Inc2 Rede Optimus Hospitalar SA2 Corvia Medical2 STZ eyetrial2 Ascletis Pharma (China) Co., Limited2 Munich Leukemia Laboratory2 Medizinische Hochschule Brandenburg Theodor Fontane2 Glycomine, Inc.2 Oliver Cornely, MD2 International Research Training Group 28042 Lohmann & Rauscher2 CRISPR Therapeutics AG2 Immunic AG2 Alumis Inc2 Gan and Lee Pharmaceuticals, USA2 GRIN Therapeutics, Inc.2 Neurocrine Biosciences2 University Hospital Ulm2 MMI (Medical Microinstruments, Inc.)2 University Hospital, Grenoble2 Massachusetts General Hospital2 Jean-Paul Belgrado2 Maastricht University Medical Center2 B. Braun Melsungen AG2 Helios Kliniken Schwerin2 Anette Buyken2 Lupin Ltd.2 Merz Therapeutics GmbH2 Kardium Inc.2 Ayham Daher2 University Heart Center Freiburg - Bad Krozingen2 UNICANCER2 Karlsburg Hospital2 Marc Bosiers, MD2 Day One Biopharmaceuticals, Inc.2 Pharming Technologies B.V.2 Alliance Foundation Trials, LLC.2 University of Rostock2 Australian and New Zealand Intensive Care Research Centre2 Shanghai Henlius Biotech2 Allergy Therapeutics2 Swiss Cancer Institute2 Suphi Taneri2 FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS2 PharmaMar2 Ataxia Study Group2 Guerbet2 Memorial Sloan Kettering Cancer Center2 Hochschule Osnabruck2 Terumo Europe N.V.2 Robert Bosch Medical Center2 EBR Systems, Inc.2 NovoCure GmbH2 Jacobs University Bremen gGmbH2 Praxis Precision Medicines2 European Foundation for Study of Chronic Liver Failure2 Relay Therapeutics, Inc.2 Otto Bock Healthcare Products GmbH2 Prevail Therapeutics2 Otto-von-Guericke University Magdeburg2 MicroPort CRM2 Noema Pharma AG2 Joseph Broderick, MD2 CytoSorbents, Inc2 Pomeranian Medical University Szczecin2 German Center for Neurodegenerative Diseases (DZNE)2 Ascendis Pharma A/S2 Endo Health GmbH2 Universitätsmedizin Mannheim2 Cook Research Incorporated2 Generate Biomedicines2 Cantonal Hospital of St. Gallen2 Comprehensive Cancer Center Munich (CCCM)2 Basilea Pharmaceutica2 VectivBio AG2 DBV Technologies2 Rocket Pharmaceuticals Inc.2 Prof. Dr. Martin Wabitsch2 Geron Corporation2 Pierre Fabre Pharma GmbH2 Idoven 1903 S.L.2 Apogee Therapeutics, Inc.2 LungenClinic Grosshansdorf2 Kailera2 Annetine Gelijns2 Sun Pharmaceutical Industries Limited2 Bluefin Biomedicine, Inc.2 Hospital Universitari Vall d'Hebron Research Institute2 Federation Francophone de Cancerologie Digestive2 Prilenia2 Johnson & Johnson Enterprise Innovation Inc.2 Aristotle University Of Thessaloniki2 The Hospital for Sick Children2 Berthold Langguth, MD, Ph.D.2 Global Foundation for the Care of Newborn Infants2 Promedon2 OncoVerity, Inc.2 Volta Medical2 Gruppo Oncologico del Nord-Ovest2 EyeBiotech Ltd.2 NovaGo Therapeutics AG2 AnaptysBio, Inc.2 Laboratoires Thea2 University Hospital Erlangen2 ML Bio Solutions, Inc.2 AvenCell Therapeutics, Inc.2 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2 OncoHost Ltd.2 Arthrex, Inc.2 Olema Pharmaceuticals, Inc.2 Santen SAS2 Seaport Therapeutics2 Zoll Medical Corporation2 Almirall, S.A.2 Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu2 Buchinger Wilhelmi Development & Holding GmbH2 University Hospital, Bordeaux2 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany2 Immatics Biotechnologies GmbH2 Mario Negri Institute for Pharmacological Research2 Spyre Therapeutics, Inc.2 InSightec2 Universitätsklinikum Köln2 Balt Extrusion2 Nova Eye, Inc.2 Infertility Treatment Center Dortmund2 Median2 Meyer Children's Hospital IRCCS2 VisionCare, Inc.2 Columbia University2 Shockwave Medical, Inc.2 Hanmi Pharmaceutical Company Limited2 Smith & Nephew, Inc.2 Amsterdam UMC2 Evangelic Hospital Kalk Cologne2 AGO Study Group2 Martin Dichgans2 ITM Solucin GmbH2 Aarhus University Hospital2 Iovance Biotherapeutics, Inc.2 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2 Bavarian Cancer Registry2 King's College Hospital NHS Trust2 AskBio Inc2 University of Birmingham2 AgNovos Healthcare, LLC2 Ottawa Heart Institute Research Corporation2 Savara Inc.2 GCP-Service International West GmbH2 Duke University2 Target PharmaSolutions, Inc.2 Biohaven Therapeutics Ltd.2 Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd2 Dyne Therapeutics2 Celcuity Inc2 European Association of Urology Research Foundation2 University Hospital, Aachen2 University of Alberta2 Children's Oncology Group2 icometrix2 Shenzhen Core Medical Technology CO.,LTD.2 AtriCure, Inc.2 AO Foundation, AO Spine2 Taewoong Medical Co., Ltd.2 Astellas Gene Therapies2 Servier Bio-Innovation LLC2 Thomas Riva2 ETOP IBCSG Partners Foundation2 Immatics US, Inc.2 Chugai Pharmaceutical2 Medacta International SA2 Microvention-Terumo, Inc.2 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2 Michael J. Fox Foundation for Parkinson's Research2 University of Rome Tor Vergata2 Kiniksa Pharmaceuticals International, plc2 Madrigal Pharmaceuticals, Inc.2 Leipzig University Medical Center2 Icahn School of Medicine at Mount Sinai2 Kerckhoff Klinik2 Emory University2 Centre Hospitalier Universitaire Vaudois2 University of Hamburg-Eppendorf2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc1 BioAegis Therapeutics Inc.1 Z-Systems1 Centinel Spine1 OncoBeta Therapeutics1 Pamgene International B.V.1 Ellipses Pharma1 Epizyme, Inc.1 University of Kansas Medical Center1 Toronto Metropolitan University1 Dr. med. Sonja Diez1 Klinikum Esslingen1 Philipp Dutkowski1 University of Sydney1 ReFlow Medical, Inc.1 Quell Therapeutics Limited1 Ceric Sàrl1 pharmaand GmbH1 Resilience1 MODAG GmbH1 Medtronic Spinal and Biologics1 Colgate Palmolive1 Innovacell GmbH1 BIONCaRT GmbH1 Theravance Biopharma1 Centre Hospitalier Universitaire de Besancon1 Vinodh Kakkassery, MD1 Periotrap Pharmaceuticals GmbH1 CVSS study1 VeonGen Therapeutics GmbH1 ARCAGY/ GINECO GROUP1 Leal Therapeutics, Inc1 Clara Angela Foundation1 Carmat SAS1 Molecure S.A.1 AllRock Bio, Inc.1 BACKBONE1 Univ.-Prof. Dr. Dr. med. Daniela Branzan1 Eggensberger OHG1 Dr. Rebecca Schule1 Timo Munz1 Varian, a Siemens Healthineers Company1 Rolfs Consulting und Verwaltungs-GmbH (RCV)1 Curasight1 Karolinska University Hospital1 Kyverna Therapeutics1 University of Massachusetts, Worcester1 Nektar Therapeutics1 IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 VU University of Amsterdam1 Rare Thyroid Therapeutics International AB1 Trans-Duodenal Concepts GmbH1 Parnassia Groep1 Waldemar Link GmbH & Co. KG1 Surgimab1 Ivy Brain Tumor Center1 Association for Innovation and Biomedical Research on Light and Image1 Janssen Biotech, Inc.1 CRISPR Therapeutics1 PSC Partners Seeking a Cure1 Hospices Civils de Lyon1 Merit Medical Systems, Inc.1 ModernaTX, Inc.1 Teknimed1 Ferrer Internacional S.A.1 Milestone Pharmaceuticals Inc.1 Sven Behrendt1 University Hospital, Tours1 Cardiac Dimensions, Inc.1 Stephanie Gräger1 Sami-Ramzi Leyh-Bannurah1 Uniformed Services University of the Health Sciences1 Stephanie Mehl1 Johannes Schiefelbein1 Alimentiv Inc.1 ResMed1 Shionogi1 Jilin Venus Haoyue Medtech Limited1 Diamens FlexCo1 Stichting European Myeloma Network1 Edward Geissler1 Neurimmune AG1 Rein Therapeutics1 Xingshun Qi1 Valo Therapeutics Oy1 University Hospital, Limoges1 Integrum1 University of Glasgow1 Hamilton Health Sciences Corporation1 Tetec AG1 ImCheck Therapeutics, an Ipsen company1 Maastricht University1 SECRETO Study Consortium1 Vastra Gotaland Region1 Khondrion BV1 PD Dr. Guram Imnadze1 Nykode Therapeutics ASA1 Orthofix s.r.l.1 Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps1 Meril Life Sciences Pvt. Ltd.1 Rotkreuzklinikum München gGmbH1 Bolt Medical1 ProQR Therapeutics1 Corxel Pharmaceuticals1 Priv.-Doz. Dr. med. Philipp Lenz1 Mathys Ltd Bettlach1 Grupo Español Multidisciplinar de Melanoma1 Sangamo Therapeutics1 Sigmund Freud PrivatUniversitat1 Vectorious Medical Technologies Ltd.1 Disc Medicine, Inc1 Children's Hospital of Philadelphia1 Protara Therapeutics1 Dr. Boris Schmitz1 University of Leeds1 OmniVision GmbH1 Virginia Commonwealth University1 GLYCAR SA (Pty) Ltd1 Biohaven Pharmaceuticals, Inc.1 Alimera Sciences1 RHEACELL GmbH & Co. KG1 Casper Rokx1 National Institute of Oncology, Hungary1 University of Liege1 NovoCure Ltd.1 OncoC4, Inc.1 BG Unfallklinik Murnau1 Bicara Therapeutics1 Zai Lab (Shanghai) Co., Ltd.1 Heidelberg Pharma AG1 Maria-Josef-Hospital Greven1 Paderborn University1 Claus Lindbjerg Andersen1 Karsten Gavenis1 Skripuletz, Thomas Prof. Dr.1 VarmX B.V.1 Aptose Biosciences Inc.1 Mizuho Corporation1 Lexicon Pharmaceuticals1 Manuel Monreal1 University of Oldenburg1 Telios Pharma, Inc.1 Loulou Foundation1 University of Utah1 Boris Böll1 AB Science1 Angela HUTTNER1 Dompé Farmaceutici S.p.A1 Prof. Dr. Dr. Birgit Burkhardt1 Edgewise Therapeutics, Inc.1 AVEO Pharmaceuticals, Inc.1 Yale University1 University Hopsital Schleswig Holstein Campus Lübeck1 Ursula Werra1 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1 Innoventric LTD1 BicycleTx Limited1 European Society of Cardiology1 Alliance for Clinical Trials in Oncology1 Prof Dr Frank Buttgereit1 Industrial Farmacéutica Cantabria, S.A.1 Razor Genomics1 41medical AG1 University College Dublin1 Aleksander Krag1 Asklepios Kliniken Hamburg GmbH1 Martin Schrappe1 Stoke Therapeutics, Inc1 Evangelisches Krankenhaus Düsseldorf1 TORL Biotherapeutics, LLC1 Orchestra BioMed, Inc1 Integrative Research Laboratories AB1 Inspire Medical Systems, Inc.1 Beneo-Institute1 Gerrit A Schubert1 Andreas Stallmach1 PhenoNet, Inc.1 Susanne Rogers1 Bial - Portela C S.A.1 The University of Texas Health Science Center, Houston1 Friedreich's Ataxia Research Alliance1 Prof. Valérie Mc Lin1 Helios University Hospital Wuppertal1 University Hospital Marburg1 University of Melbourne1 HistoSonics, Inc.1 NeoChord1 Bioverativ, a Sanofi company1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Robert Perneczky1 Sied Kebir1 Geistlich Pharma AG1 Gossamer Bio USA, Inc.1 Artivion Inc.1 AvenCell Europe GmbH1 Juan Carlos M. Andreani MD1 Fresenius Kabi SwissBioSim GmbH1 Hellenic Institute for the Study of Sepsis1 EspeRare Foundation1 Philip Morris Products S.A.1 Svenja Taubner1 Prof. Dr. Frank Behrens1 Frank G. Holz1 Hemovent GmbH1 Inossia AB1 Mundipharma Research Limited1 Christian S. Meyhoff1 Dr. Paul Buderath1 Iperboreal Pharma Srl1 Julia Eder1 Instituto de Investigación Hospital Universitario La Paz1 Valentina Puentmann1 Apollo Therapeutics Ltd1 OD-OS MacuTherm GmbH1 Advanced Accelerator Applications1 Zura Bio Inc1 Sitryx Therapeutics Ltd1 Fore Biotherapeutics1 brenner baruch1 Britannia Pharmaceuticals Ltd.1 Sam Chun Dang Pharm. Co. Ltd.1 Immunophotonics, Inc.1 LuSeed Vascular LTD.1 PedNet Haemophilia Research Foundation1 Panbela Therapeutics, Inc.1 Endospan Ltd.1 SAb Biotherapeutics, Inc.1 BSN Medical GmbH1 Bionime Corporation1 Centre Leon Berard1 North Karelia Central Hospital1 Matthias Stuber1 Shape Memory Medical, Inc.1 Bordeaux Colorectal Institute Academy1 Proxima Health, Inc.1 Cliniques universitaires Saint-Luc- Université Catholique de Louvain1 Institute of Molecular and Clinical Ophthalmology Basel1 LivaNova1 University of Greifswald1 BioNTech Cell & Gene Therapies GmbH1 Corcym S.r.l1 Eva Heim1 LimmaTech Biologics AG1 Ethicon Endo-Surgery1 Vektor Medical1 Mitra Bio1 NeuroDerm Ltd.1 Anocca AB1 Rapamycin Holdings Inc.1 Dr. Gerhard Mann chem.-pharm. Fabrik GmbH1 Deepull Diagnostics S.L.1 Thomas Dirschka1 AriBio Co., Ltd.1 DKMS gemeinnützige GmbH1 Wave Life Sciences USA, Inc.1 Neurocrine Switzerland GmbH1 Prof. Dr. Paul Brinkkoetter1 Somagenetix AG1 Kedrion S.p.A.1 Napo Therapeutics, S.p.A.1 Saluda Medical Pty Ltd1 Kupando GmbH1 Martin-Luther-Universität Halle-Wittenberg1 Zogenix, Inc.1 Arbor Biotechnologies1 Uptake Medical Technology, Inc.1 LeonaBio1 Gustave Roussy, Cancer Campus, Grand Paris1 Lea Kölsch1 Karl Heinrich Scholz1 Maria Joyera Rodríguez1 Oncolytics Biotech1 Johannes Dorst1 Endomagnetics Ltd.1 Marc Donath1 HUYABIO International, LLC.1 Carl Zeiss Meditec AG1 Noah Labs1 Klinikum Dortmund Wirbelsäulenchirurgie1 Fondazione IRCCS Policlinico San Matteo di Pavia1 Stefanie Brassen1 Dr. Andreas Ziegler1 Prof. Dr. Jan Liman1 Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen1 DualityBio Inc.1 Health and Medical University Potsdam1 Bold Therapeutics, Inc.1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 UroTrials Company (GmbH)1 X4 Pharmaceuticals1 National Cancer Institute (NCI)1 Janssen-Cilag International NV1 Laurenz Kopp Fernandes1 German Society for Pediatric Oncology and Hematology GPOH gGmbH1 Nova Laboratories Limited1 Sophia Genetics SAS1 IlluminOss Medical, Inc.1 Vall d'Hebron Institute of Oncology1 Paris Translational Research Center for Organ Transplantation1 Forma Therapeutics, Inc.1 Italian Sarcoma Group1 Electra Therapeutics Inc.1 Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1 Helios Klinikum Pforzheim1 Y-mAbs Therapeutics1 RyCarma Therapeutics, Inc.1 Das Radiologische Zentrum1 Sebastian Zschaeck1 Christoph Königs1 Merz Aesthetics GmbH1 University Hospital, Ghent1 OncoZenge AB1 Prof. Stavros Konstantinides, MD1 Berlin Heart GmbH1 Anthos Therapeutics, Inc.1 Helsinki University Central Hospital1 Fundació d'investigació Sanitària de les Illes Balears1 GE Healthcare1 Cochlear1 Canadian Cancer Trials Group1 Michael Tobias Hirschmann1 ThermoMind Ltd.1 MediWound Ltd1 Enrico De Toni1 IRCCS Azienda Ospedaliero-Universitaria di Bologna1 Calico Life Sciences LLC1 Alleviant Medical, Inc.1 Restore Medical Ltd1 Lund University1 FCRE (Foundation for Cardiovascular Research and Education)1 H. Lundbeck A/S1 Wim Janssens1 Alexandra Miriam Kiess1 Medtronic Cardiac Rhythm and Heart Failure1 AWOgyn1 KU Leuven1 VisDura, Inc.1 OSE Immunotherapeutics1 Eidos Therapeutics, a BridgeBio company1 Christina Berr. MD1 University Children's Hospital, Zurich1 Cardionovum GmbH1 Fundación EPIC1 Akcea Therapeutics1 Sellas Life Sciences Group1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 Gyroscope Therapeutics Limited1 Western Sydney Local Health District1 Medstar Health Research Institute1 Pulmovant, Inc.1 Inmunova S.A.1 Imagine Institute1 ONL Therapeutics1 IU University of Applied Sciences1 Inventiva Pharma1 Minoryx Therapeutics, S.L.1 Distalmotion SA1 Christian Bolenz1 Prof. Arasch Wafaisade1 SciBase AB1 Australasian Gastro-Intestinal Trials Group1 Intensity Therapeutics, Inc.1 Amal Therapeutics1 TolerogenixX GmbH1 University College Cork1 Zealand University Hospital1 Dren Bio1 Reprieve Cardiovascular, Inc1 Stiftung Institut fuer Herzinfarktforschung1 Xcovery Holdings, Inc.1 Coldplasmatech1 Sana Klinikum Offenbach1 Orthofix Inc.1 European LeukemiaNet1 Chinese Academy of Sciences1 OWKIN1 Olga Ramich (formerly Pivovarova)1 Photocure1 Worcester Polytechnic Institute1 Christian Dorfer1 V-Wave Ltd1 Mineralys Therapeutics Inc.1 NSC-Therapeutics1 Cutting Edge SAS1 NVT GmbH1 Christiana Franke1 APrevent Biotech GmbH1 JenaValve Technology, Inc.1 Christian Paret1 Pentax Medical1 Pulmair Medical, Inc.1 Contineum Therapeutics1 Freya Biosciences ApS1 Amryt Pharma1 PMV Pharmaceuticals, Inc1 John Neoptolemos1 Sumitomo Pharma America, Inc.1 University of Minnesota1 Tenax Therapeutics, Inc.1 Venus MedTech (HangZhou) Inc.1 Partner Therapeutics, Inc.1 Ambulanzpartner Soziotechnologie APST GmbH1 Aresus Pharma GmbH1 Fondazione Michelangelo1 Skyhawk Therapeutics, Inc.1 ORNND - Operating Room Nurse Network Denmark1 SOLTI Breast Cancer Research Group1 RhoVac APS1 Scholar Rock, Inc.1 Acesion Pharma1 Shunmei Medical1 Swiss GO Trial Group1 Medicalschool Hamburg1 Navigator Medicines, Inc.1 Prof. Dr. Matthis Synofzik1 Aarhus University Hospital Skejby1 Verastem, Inc.1 Ascilion AB1 CentroDerm GmbH1 University of Bergen1 Apreo Health, Inc.1 Apollo Medical Optics, Ltd1 Montefiore Medical Center1 QurAlis Corporation1 Diagram B.V.1 Contura1 Galecto Biotech AB1 Angel Argiles1 San Raffaele University1 WELT corp1 Shanghai Argo Biopharmaceutical Co., Ltd.1 University of Siena1 Trace Neuroscience, Inc.1 Tobias Feuchtinger1 University of Wisconsin, Madison1 Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz1 Malek Bajbouj1 Enliven Therapeutics1 Renaissance Pharma Ltd.1 Muehlenkreiskliniken, MKK1 Splice Bio1 Erbe Elektromedizin GmbH1 Baxalta now part of Shire1 neurescue1 Fundacio Puigvert1 Cybin IRL Limited1 Spark Therapeutics, Inc.1 PedAL BCU, LLC1 Priovant Therapeutics, Inc.1 Pentixapharm AG1 Olistic Research Labs S.L.1 Universitat Internacional de Catalunya1 DePuy International1 Delcath Systems Inc.1 Elios Vision, Inc.1 Hazem Omran1 Acrotech Biopharma Inc.1 Episurf Medical Inc.1 MedImmune LLC1 Globus Medical Inc1 Cardiawave SA1 Vico Therapeutics B. V.1 Queen Silvia Children's Hospital, Gothenburg, Sweden1 The European Forum for Research and Education in Allergy and Airway Diseases1 Marien Hospital Herne1 Global Antibiotics Research and Development Partnership1 Stealth BioTherapeutics Inc.1 Tanabe Pharma America, Inc.1 CUTISS AG1 University Hospital Bergmannsheil Bochum1 HepaRegeniX GmbH1 CuraCell TX AB1 BAAT Medical Products B.V.1 University of Milano Bicocca1 Adcendo ApS1 Knappschaft Kliniken GmbH1 OHB Neonatology Ltd.1 Integra LifeSciences Corporation1 Masaryk University1 International Extranodal Lymphoma Study Group (IELSG)1 Hangzhou Valgen Medtech Co., Ltd1 Isofol Medical AB1 International CTEPH Association1 XVIVO Perfusion1 Michael Hoelscher1 SonoClear AS1 Dizal Pharmaceuticals1 Morair Medtech, LLC1 Nuvaira, Inc.1 Mayo Clinic1 Tobias Moser1 Deniz Göcebe1 Buda Health Center1 Alesta Therapeutics1 Beijing InnoCare Pharma Tech Co., Ltd.1 Stryker Craniomaxillofacial1 Klinikum Stuttgart1 University of Modena and Reggio Emilia1 Medtronic - MITG1 Biotronik, Inc.1 Phenox GmbH1 IGLESIAS Juan Fernando1 BioTex, Inc.1 Boston Children's Hospital1 Insight Molecular Diagnostics1 Turning Point Therapeutics, Inc.1 Citryll BV1 ABX advanced biochemical compounds GmbH1 Unfallkrankenhaus Berlin1 Kyowa Kirin Pharmaceutical Development Ltd1 PROCEPT BioRobotics1 Royal Brompton & Harefield NHS Foundation Trust1 Corbus Pharmaceuticals Inc.1 PDC*line Pharma SAS1 Acotec Scientific Co., Ltd1 P+F Products + Features GmbH1 University of Virginia1 Elixir Medical Corporation1 Imbria Pharmaceuticals, Inc.1 Norwegian University of Science and Technology1 SK Life Science, Inc.1 NGMedical GmbH1 Dr. Yaroslav Winter1 Allievex Corporation1 Steffen Paschen1 Vega Therapeutics, Inc1 Capnetz Stiftung1 University of Hohenheim1 Jules Bordet Institute1 Prof. Dr. Juergen Wolf1 FIDAM RDC1 Beeline Medicines Corporation1 Henrik Bo Wiberg Larsson1 Aziende Chimiche Riunite Angelini Francesco S.p.A1 TheraOp1 Catholic University of Applied Sciences Mainz1 Forschungszentrum Juelich1 Vifor Fresenius Medical Care Renal Pharma1 Harald Gündel1 European Society of Anaesthesiology1 NYU Langone Health1 GWT-TUD GmbH1 Robocath1 TRiCares1 Vera Guttenthaler1 Grey Wolf Therapeutics1 Dr. Nils B. Kroemer1 Prof. Dr. med. M.Sc. Georg Griesinger1 Physio-Assist1 CardioRenal Systems, Inc.1 Windward Bio1 Kumquat Biosciences Inc.1 CHDI Foundation, Inc.1 Forschungsinstitut der Diabetes Akademie Mergentheim1 Torsten Beyna1 Britta Trautwein1 St. Antonius Hospital Gronau1 Tern Therapeutics, LLC1 Priothera SAS1 Arbor Research Collaborative for Health1 enGene, Inc.1 Toralf Reimer, MD PhD1 University of Miami1 Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 TC Erciyes University1 Wren Laboratories LLC1 Desentum Oy1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Imricor Medical Systems1 ARCIM Institute Academic Research in Complementary and Integrative Medicine1 Nicolas Schlegel1 Bellus Health Inc. - a GSK company1 Fundacao Champalimaud1 Atea Pharmaceuticals, Inc.1 Rna Diagnostics Inc.1 ECOG-ACRIN Cancer Research Group1 Fondazione Don Carlo Gnocchi ETS1 Matthias Friedrich1 Prof. Dr. med. Claus Rödel1 Christian Schmidt, MD1 Nobel Biocare1 Invivoscribe, Inc.1 Jung Diagnostics GmbH1 Exactech1 University of British Columbia1 Universitair Ziekenhuis Brussel1 Rijnstate Hospital1 Neo Medical SA1 ExThera Medical Corporation1 IFOM ETS - The AIRC Institute of Molecular Oncology1 BioLineRx, Ltd.1 Gemini Eye Clinic1 Berlin Institute of Health @ Charité1 Brigham and Women's Hospital1 NS Pharma, Inc.1 St. Anna Kinderkrebsforschung1 Ovesco Endoscopy AG1 TME Pharma AG1 Esteve Pharmaceuticals, S.A.1 Thomas Ernst, PD Dr. med.1 Kinderkrankenhaus auf der Bult1 Aura Biosciences1 Gymna Uniphy1 EUthyroid1 Beaver-Visitec International, Inc.1 Tectonic Therapeutic1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 University Medical Center Nijmegen1 Echosens1 WALA Heilmittel GmbH1 M.D. Anderson Cancer Center1 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 Michaël Hofer1 Medtronic Neurovascular Clinical Affairs1 Vivasure Medical Limited1 Klinikum Hersfeld-Rotenburg1 Stadtisches Klinikum Dresden1 Endotronix, Inc.1 St George's, University of London1 Medical University of South Carolina1 Prof. Dr. Julia Glombiewski1 Christian Schulze1 Akouos, Inc.1 Claus Cursiefen1 University of Dublin, Trinity College1 Maquet Cardiovascular1 Institut Cancerologie de l'Ouest1 Protagonist Therapeutics, Inc.1 Eledon Pharmaceuticals1 University Eye Hospital, Freiburg1 Invibio Ltd1 NewAmsterdam Pharma1 Tampere University1 Prof. Dr. Stephan Weidinger1 Definium Therapeutics US, Inc.1 AC Immune SA1 Infectopharm Arzneimittel GmbH1 The Lowy Medical Research Institute Limited1 Bosch Quantum Sensing GmbH1 Haemophilia Centre Rhine Main1 Wolfgang Kemmler, PhD1 POROUS GmbH1 OpenGenome1 Tom Hühne1 Leibniz-Institut für Resilienzforschung (LIR) gGmbH1 Janssen-Cilag G.m.b.H1 University of Pittsburgh1 DEO NV1 Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1 Profound Medical Inc.1 University of California, San Francisco1 Firalis SA1 Barbara Wolff-Winiski1 Vedanta Biosciences, Inc.1 Blue Earth Therapeutics Ltd1 European Clinical Research Alliance for Infectious Diseases (ECRAID)1 Gubra A/S1 Assembly Biosciences1 COMPASS Pathways1 Wandercraft1 Applied Therapeutics, Inc.1 Mission Therapeutics1 SecuraBio1 Motiva USA LLC1 Dairy Goat Co-operative (N.Z.) Limited1 University Hospital, Montpellier1 Peter Rossing1 4TEEN4 Pharmaceuticals GmbH1 Javier P. Gisbert1 Semmelweis University1 Novian Health Inc.1 Ascendis Pharma Growth Disorders A/S1 Göteborg University1 Dr. Falk Pharma GmbH1 Matthias Griese1 Lexeo Therapeutics1 Inhibrx Biosciences, Inc1 4C Medical Technologies, Inc.1 Prof. Dr. med. Andreas Halder1 RNATICS GmbH1 Kepler University Hospital1 University of Bayreuth1 Jade Biosciences, Inc.1 Mylan Pharmaceuticals Inc1 Research Maatschap Cardiologen Rotterdam Zuid1 Change Accelerator in Respiratory Care1 Exciva GmbH1 SymBio Pharmaceuticals1 Puerta de Hierro University Hospital1 Lisette Nixon1 Neuravi Limited1 XEOS Medical1 PTC Therapeutics1 Norgine1 Galimedix Therapeutics Inc1 Prof. Dr. Richard F Schlenk1 Abalos Therapeutics GmbH1 Artiva Biotherapeutics, Inc.1 Idorsia Pharmaceuticals Ltd.1 G&G Biotechnology Ltd.1 The University of Hong Kong1 Thuasne1 Johann E Gudjonsson MD PhD1 Ceretrieve Ltd.1 Neurothera Labs Inc.1 Servier Affaires Médicales1 Chong Kun Dang Pharmaceutical1 REVA Medical, Inc.1 UCB BIOSCIENCES, Inc.1 Parkinson's Clinic in Beelitz-Heilstatten1 Bundeswehr University Munich1 Advesya SAS1 Erasme University Hospital1 Heart Centre Rotenburg1 Glycostem Therapeutics BV1 Zydus Therapeutics Inc.1 Julius Clinical1 Javelin Medical1 Poitiers University Hospital1 Helmholtz Centre for Infection Research1 Maximilian Pfau1 Global Coalition for Adaptive Research1 Biotest1 Cabaletta Bio1 Andreas Guenther1 Calcilytix Therapeutics, Inc., a BridgeBio company1 Texas Scottish Rite Hospital for Children1 Michael Dill1 Contego Medical, Inc.1 University Hospital, Gasthuisberg1 Associazione Italiana Ematologia Oncologia Pediatrica1 Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD1 University of Kassel1 TransThera Sciences (Nanjing), Inc.1 Immutep S.A.S.1 Guardant Health, Inc.1 AIRNA Corporation1 TriReme Medical, LLC1 Molnlycke Health Care AB1 Waldfriede Hospital1 Weizmann Institute of Science1 Immunome, Inc.1 Granular Therapeutics Limited1 Science Corporation1 dr. M.J.N.L. Benders1 Airway Therapeutics, Inc.1 Oruka Therapeutics, Inc.1 Johns Hopkins University1 Symbios Orthopedie SA1 Santersus AG1 Acumen Pharmaceuticals1 Pirus Ghadjar1 Teleflex1 AO Clinical Investigation and Publishing Documentation1 Dr. F. Köhler Chemie GmbH1 SystImmune Inc.1 McMaster University1 Kliniken Beelitz GmbH1 USWM CT, LLC1 Alentis Therapeutics AG1 Newcastle University1 THYROSCOPE INC.1 Wageningen University1 Nadja Naenni1 Greenwich LifeSciences, Inc.1 Harding Center for Risk Literacy1 invoX Pharma Limited1 Technical University of Dortmund1 Alaa Emara1 Colorado Prevention Center1 INNODIA iVZW1 Rezolute1 Vesalio1 Dianthus Therapeutics1 Augenklinik Ahaus G + H GmbH & Co. KG1 Tenaya Therapeutics1 Akeso1 Sequana Medical N.V.1 Nocion Therapeutics1 Inhibikase Therapeutics1 Karolinska Institutet1 Wissenschaftliches Institut Bethanien e.V1 BioClin BV1 Pulmonx Corporation1 Xeltis1 Vividion Therapeutics, Inc.1 TRB Chemedica AG1 Montreal Heart Institute1 University of L'Aquila1 Colospan Ltd.1 Eclipse Medical Ltd.1 Sanaria Inc.1 Glaukos Corporation1 Immuneering Corporation1 Stephan Baldus1 Vanda Pharmaceuticals1 Harmony Biosciences Management, Inc.1 Rhythm Pharmaceuticals, Inc.1 D3 Bio (Wuxi) Co., Ltd1 Steba Biotech S.A.1 Merz Pharmaceuticals GmbH1 Endeavor Biomedicines, Inc.1 Roche Diagnostics GmbH1 Rene Mantke1 Annika Kurreck1 Alcyone Therapeutics, Inc1 Orthomol Pharmazeutische Vertiebs GmbH1 Vivet Therapeutics SAS1 Prothya Biosolutions1 University Hospital, Toulouse1 Indiana University1 The Leeds Teaching Hospitals NHS Trust1 Prof. Dr. Hartmut Goldschmidt1 Prof. Dr. med. Andreas Hochhaus1 Marek Lommatzsch1 Kyowa Kirin Co., Ltd.1 Philippe ROUSSELOT1 Stefan Hagel1 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1 GreenBone Ortho S.p.A.1 Sebastian Probst1 Nexira1 Zentralklinik Bad Berka1 Jan-Christoph Lewejohann1 NEOS Surgery1 Vicore Pharma AB1 SpectraCure AB1 Truway Health, Inc.1 Acrivon Therapeutics1 Orphalan1 Liquidia Technologies, Inc.1 Micro Medical Solution, Inc.1 ImmunoRegister gUG1 SRH Gesundheitszentrum Bad Herrenalb1 Hidde van der Ploeg1 Sunnybrook Health Sciences Centre1 Department of Cardiology German Heart Center Munich TUM University Hospital1 Grifols Therapeutics LLC1 QualiMed Innovative Medizinprodukte GmbH1 4D Molecular Therapeutics1 Dimerix Bioscience Pty Ltd1 SoniVie Inc.1 Beyond Batten Disease Foundation1 Universitatsmedizin Mainz - 1. Medizinische Klinik1 Giuseppe Tarantini1 European Institute of Oncology1 Silence Therapeutics plc1 Tobias Schreiber1 Larry Hinkson1 Löwenstein Medical Technology GmbH & Co. KG1 IRCCS Sacro Cuore Don Calabria di Negrar1 Mats Heyman1 Provention Bio, a Sanofi Company1 ARS Pharmaceuticals, Inc.1 Intressa Vascular SA1 Stanford University1 Samsung Bioepis Co., Ltd.1 Annexon, Inc.1 Pharmazz, Inc.1 Bambino Gesù Hospital and Research Institute1 Aron Onerup1 Prof. Dr. Thomas Luft1 Hannah Schaefer1 VDyne, Inc.1 Medtronic MiniMed, Inc.1 Stryker Neurovascular1 MaaT Pharma1 Nikolaj Frost MD1 CarThera1 ReAlta Life Sciences, Inc.1 Zimmer, GmbH1
Site location
Berlin1587 Hamburg893 Essen765 Dresden714 Heidelberg626 Cologne619 Leipzig513 München510 Hanover487 Tübingen454 Bonn422 Düsseldorf409 Munich398 Freiburg im Breisgau394 Erlangen374 Frankfurt369 Münster359 Frankfurt am Main343 Ulm343 Mainz336 Würzburg296 Aachen266 Augsburg248 Kiel234 Lübeck225 Halle225 Bochum212 Mannheim204 Jena202 Göttingen198 Giessen167 Chemnitz166 Regensburg141 Stuttgart119 Bad Oeynhausen106 Marburg100 Homburg99 Bielefeld97 Bremen93 Magdeburg92 Dortmund85 Rostock82 Greifswald79 Herne75 Braunschweig75 Nuremberg69 Oldenburg68 Duisburg65 Darmstadt63 Gauting63 Bad Bentheim58 Kassel55 Karlsruhe54 Esslingen am Neckar53 Bad Nauheim53 Erfurt52 Großhansdorf52 Bad Homburg49 Amberg47 Aschaffenburg47 Bad Krozingen45 Bamberg44 Minden43 Cottbus40 Nürtingen39 Heilbronn38 Bad Saarow37 Potsdam35 Bayreuth35 Immenhausen34 Dachau34 Koblenz33 Wuppertal33 Georgsmarienhütte32 Bottrop29 Mönchengladbach28 Schwerin28 Dessau28 Bad Berka28 Ludwigshafen27 Neuss26 Gera26 Wiesbaden26 Trier24 Coburg24 Buxtehude24 Bad Segeberg21 Detmold21 Mutlangen20 Offenbach20 Ahaus20 Osnabrück20 Bad Neustadt an der Saale19 Böblingen18 Ravensburg18 Paderborn18 Witten17 Altenburg17 Bergisch Gladbach17 Brandenburg an der Havel16 Sankt Augustin15 Hemer15 Ludwigsburg15 Elsterwerda15 Baden-Baden15 Löwenstein15 Villingen-Schwenningen15 Saarbrücken15 Ahrensburg14 Bendorf14 Konstanz14 Landshut14 Langen13 Bad Mergentheim13 Flensburg13 Bramsche13 Kaiserslautern13 Multiple Locations13 Brandenburg13 Höchheim12 Lüneburg12 Ludwigshafen am Rhein12 Hamm12 Weinheim12 Ratingen12 Rosenheim11 Kempten11 Friedrichshafen11 Langenau11 Krefeld11 Mettmann11 Moers11 Erbach im Odenwald11 Fürth10 Bünde10 Bad Friedrichshall10 Goettigen10 Bad Rothenfelde10 Deggendorf10 Siegen10 Fulda10 Bremerhaven10 Oldenburg in Holstein10 Donauwörth10 Arnsberg9 Immenstadt im Allgäu9 Coswig9 Solingen9 Recklinghausen8 Schwäbisch Hall8 Gütersloh8 Buchholz8 Ansbach8 Bad Bevensen8 Bernau8 Planegg8 Blankenfelde-Mahlow8 Münich7 Remscheid7 Bernau bei Berlin7 Falkensee7 Rheine7 Sendenhorst7 Schleswig7 Pforzheim7 Kempten (Allgäu)7 Bad Bramstedt7 Biberach7 Neubrandenburg7 Bad Doberan7 Hessisch Oldendorf7 Göppingen7 Rüdersdorf7 Bruchsal6 Worms6 Hagen6 Gelnhausen6 Hessen6 Schönau am Königssee6 Jerichow6 Wolfsburg6 Borstel6 Murnau am Staffelsee6 Lingen6 Deggingen6 Wetzlar6 Velbert6 Donaustauf6 Goch6 Winnenden6 Mahlow6 Erding6 Westerstede6 Mitte6 Lahr5 Bad Reichenhall5 Traunstein5 Kulmbach5 Straubing5 Hof5 Riesa5 Manheim5 Beelitz5 Karlsburg5 Homburg/Saar5 Ingolstadt5 Kirchheim unter Teck5 Gerlingen5 Aalen5 Reutlingen5 Datteln5 Leverkusen5 Beelitz-Heilstätten5 Cloppenburg5 Taufkirchen5 Berlin-Spandau5 Herford4 Bayern4 Hösbach4 Borna4 Dülmen4 Celle4 Mechernich4 Mülheim4 Herxheim4 Stralsund4 Merzig4 Hildesheim4 Memmingen4 Ebersberg4 Aue4 Bad Kreuznach4 Eisenach4 Passau4 Many Locations4 Pirna4 Nuthetal4 Radeberg4 Delitzsch4 Bechhofen4 Berlin-Zehlendorf4 Erdgeschoss4 Wesel4 Gronau4 Kirchheim4 Eisleben Lutherstadt4 Buch4 Stade4 Sulzbach4 Eschweiler4 Meerbusch3 Albstadt3 Frankfurt A. Main3 Bad Liebenwerda3 Andernach3 Greven3 Giesen3 Düren3 Freiburg I. Breisgau3 Heidenheim3 Neumünster3 Wangen3 Hürth3 Grevenbroich3 Weiden3 Eisenberg3 Reinbek3 Haag in Oberbayern3 Troisdorf3 Neuruppin3 Rotenburg (Wümme)3 Wolfach3 Lünen3 Fürstenwalde3 Neu-Isenburg3 Vogtareuth3 Eggenfelden3 Neu-Ulm3 Offenburg3 Torgau3 Bad Aibling3 Zwickau3 Markkleeberg3 Hochheim am Main3 Bautzen3 Unterhaching3 Alsfeld3 Frankfurt a.M.3 Selters3 Weiden in Der Oberpfalz3 Hohenmölsen3 Bad Nenndorf3 Tettnang3 Wallerfing3 Steglitz3 Itzehoe3 Sachsen3 Frankfurt/M.3 Esslingen a.N.3 Wilhelmshaven3 Garmisch-Partenkirchen3 Geesthacht3 Frankfurt (Oder)3 Mainz Am Rhein3 Müllheim2 Daaden2 Holstein2 Friedrichsthal2 Saint Ingbert-Oberwürzbach2 Schenefeld2 Emmendingen2 Köln - Dünnwald2 Mainz-GE2 Bietigheim2 Münnerstadt2 Freiburg2 Filderstadt2 Rendsburg2 Meppen2 Auerbach2 Cuxhaven2 Hennigsdorf2 Oeynhausen2 Baden-Warttemberg2 Heinsberg2 Olsberg2 Obertshausen2 Allensbach2 Quedlinburg2 Pommelsbrunn2 Bad Hersfeld2 Immenstädt2 Muenchen-Gauting2 Multiple Sites2 Kehl-kork2 Bocholt2 Schwandorf in Bayern2 Leer2 Neumarkt2 Singen2 Landsberg am Lech2 Munster2 Greifswald Hansestadt2 Templin2 Stadtroda2 Kempen2 Hattingen2 Oberhausen2 Günzburg2 Tostedt2 Schorndorf2 Wiesloch2 Kremmen2 Hamburg-Nord2 Überlingen2 Landsberg2 Saalfeld2 Bad Oldesloe2 Hannover2 Brakel2 Burgau2 Peine2 Hoppegarten2 Stuhr2 Ahlen2 Würselen2 Mörfelden-Walldorf2 Karlsbad2 Neuburg A.d. Donau2 Gladbeck2 Freiberg2 Bad Abbach2 Herrsching am Ammersee2 Haßfurt2 Sindelfingen2 Heide2 Wipperfürth2 Kehl2 Radebeul2 Damme2 Gelsenkirchen2 Meisenheim2 Gummersbach2 Wedding2 Schwetzingen2 Sande2 Eppendorf2 Goslar2 Berg2 Kerpener2 Koelner Platz 12 Ibbenbueren2 Köpenick1 Offenbach/ Main1 Nettetal1 Hamburg-Eppendorf1 Elsenfeld1 Hechingen1 Warendorf1 Mölln1 Rehlingen-Siersburg1 Dinslaken1 Bietigheim-Bissingen1 Gifhorn1 München Gauting1 Bad Wildungen1 Füssen1 Löhne1 Bückeburg1 Zittau1 Freudenstadt1 Hohenstein-Ernsttal1 Wildeshausen1 Bad Feilnbach1 Dessau Roblau1 Brüggen1 Waidhaus1 Willich1 Fritzlar1 Landstuhl1 Berin1 Blaubeuren Abbey1 Wangen I. Allgaeu1 Dornstadt1 Weilheim1 Ennepetal1 Klinik Für Kinder- Und Jugendmedizin1 Schleswig-Holstein1 D Sseldorf1 Püttlingen1 Several Locations1 Harburg1 Bogenhausen1 Ehingen1 Homburg / Saar1 Schwerte1 Bad Klosterlausnitz1 Bad Sülze1 Gailingen1 Daun1 Schwedt1 Friedberg1 Buckow1 Erbach/Odenwald1 Travemünde1 Hetzdorf1 Sundern1 Buedelsdorf1 Forchheim1 Sanderbusch1 Gdansk1 Bad Schlema1 Ludwigsfelde1 Naumburg1 Waldshut-Tiengen1 Reinfeld1 Mühlheim An Der Ruhr1 Wölfersheim1 Weyhe-Kirchweyhe1 Coppenbrügge1 Homburg/ Saar1 Brilon1 Oberschleißheim1 Melle1 Koblenz Am Rhein1 Onsabrück1 Perleberg1 Lubin1 Obergünzburg1 Gangelt1 Speyer1 Beuel1 Mühlacker1 Bönnigheim1 Bretten1 Müchen1 Prien am Chiemsee1 Brühl1 Hoyerswerda1 Haltern am See1 Bad Wildbad1 Please Refer to Project Homepage For Details (see Link Below)1 Friedrichsdorf1 Drensteinfurt1 Rüsselsheim am Main1 Haslach1 Basel1 Steinfurt1 Saint Ingbert1 Apolda1 Balingen1 Nordenham1 Grosshandorf1 Haag I.Ob1 Burgwedel1 Erkelenz1 Cologn1 Martinsried1 Haus1 Eichstätt1 Ganderkesee1 Nordhausen1 Stadtlohn1 Gröbenzell1 Ilmenau1 Gräfelfing1 Guenzburg1 Bruchhausen-Vilsen1 Vechta1 Nordrhein Westfalen1 Plettenberg1 Strausberg1 Lorsch1 Stadtallendorf1 Hagenow1 Munchen, Bayern1 Weisbaden1 Muenchen1 Charlottenburg1 Köln1 Barsinghausen1 Saint Augustin1 Demmin1 Ehringshausen1 Hanau1 Saarlouis1 D Ren1 L Rrach1 M Nchen1 N Rnberg1 Neustadt Am R Benberge1 Saarbr Cken1 Sindelfinden1 Lemgo1 Rheinstetten1 Lauf an der Pegnitz1 Panketal1 Simmerath1 Iserlohn1 Bad Elster1 Langensteinbach1 Donaueschingen1 Dorf Mecklenburg1 Bad Belzig1 Rednitzhembach1 Flörsheim1 Eilenburg1 Sonneberg1 Stralstund1 Kork1 Wriezen1 Dresden Sachsen1 Frankfurt Am Main Hessen1 Kln Nordrhein-westfalen1 Warzburg1 Düesseldorf1 Untermeitingen1 Herdecke1 Offenbach/Main1 Hösbach1 Ostfildern1 Karlstadt am Main1 Hallbergmoos1 Weinsberg1 Grohansdorf1 Hohenfelde B Bad Doberan1 Immenstadt and Kempten1 Hettingen1 Nagold1 Dillingen an der Donau1 Landau1 Dingolfing1 Augsburg, by1 Renningen1 Friedrichshain1 Markgröningen1 Salzkotten1 Homburg - Saar1 Arnsdorf1 Bad Soden1 Münchberg1 Hausham1 Keil1 Tuttlingen1 Allemagne1 Vogelsang-gommern1 Traben-Trarbach1 Liepzig1 Alzenau in Unterfranken1 Oppenheim1 Wittenberg1 Aurich1 Baden-Württemberg1 Grombuehl1 Bonn-Duisdorf1 Bad Berleburg1 Laubach1 Rotenburg an der Fulda1 Ahrweiler1 Hohenstein-Ernstthal1 Homberg (Efze)1 Greifenstein1 Alsfed1 Burg1 Biberach an der Riss1 Kelheim1 Altötting1 Sigmaringen1 Baden1 Ilsede1 Alzey1 Esslingen A. N.1 Grünwald1 Bremenhaven1 Muehldorf Am Inn1 Langenbeckstraße 11 Kandel1 Nordrhein-Westfalen1 Rheinland-Pfalz1 Hohen Neuendorf1 Schweinfurt1 Locations1 Schönau1 Schweigen-Rechtenbach1 Lauterbach1 Dessau-RoBlau1 Spandau1 Bad Herrenalb1 Adernach1 Schmallenberg1 Bethel1 Gutenberg1 Rhein1 Saarbrücken-Dudweiler1 Freising1 Hombourg1 Freyung1 Holzminden1
All 638 locations
Target enrolment
to

Trials in this register

5062 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Active, closed
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma
NCT06642506Esophagus Adenocarcinoma, Esophagus Cancer, Metabolome, Mass Spectrometry
Ludwig-Maximilians - University of Munich
Observational
20
Munich
2024-10-06
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Berlin, Cologne, Heidelberg
2024-10-05
Recruiting
Abiomed Impella RT-DAQ - Observational Study
NCT06308055Cardiogenic Shock
Abiomed Inc.
Observational
125
Aachen, Kiel
2024-10-04
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc
Phase 3
2,150
Frankfurt am Main, Homburg, Leipzig, Lübeck, Berlin
2024-10-04
Active, closed
AstraZeneca
Phase 3
768
Berlin-Zehlendorf, Essen, Georgsmarienhütte, Großhansdorf, Hamburg, Löwenstein, Nuremberg
2024-10-04
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
Homburg, Jena, Munich
2024-10-03
Recruiting
Zealand University Hospital
Not applicable
300
Rostock
2024-10-03
Recruiting
SoniVie Inc.
Not applicable
261
Dresden, Erlangen, Frankfurt, Freiburg im Breisgau, Hamburg, Herne, Homburg, Leipzig
2024-10-03
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Beelitz, Dresden, Düsseldorf, Kassel, Leipzig, Marburg, München, Münster
2024-10-02
By invitation
GlyCoBrain Observational Study
NCT06679088Healthy, Adult
Paderborn University
Observational
350
Paderborn
2024-10-01
Recruiting
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
NCT06569602Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases
Edwards Lifesciences
Observational
500
Bad Berka, Bad Nauheim, Bad Neustadt an der Saale, Bad Oeynhausen, Berlin, Bonn, Dortmund, Essen
2024-10-01
Recruiting
Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study
NCT05969431Stress, Psychological, Father-Child Relations, Premature Birth
University of Cologne
Observational
120
Cologne
2024-10-01
Recruiting
Deutsches Herzzentrum Muenchen
Not applicable
60
München
2024-10-01
Recruiting
Investigation of the Audible ICD Alert Tone
NCT06388382Implantable Defibrillator User
Universitätsklinikum Köln
Observational
150
Cologne
2024-10-01
Recruiting
At-Home tDCS as Maintenance Therapy
NCT07269964MDD, Severe Depression, Major Depressive Episode
Technical University of Munich
Not applicable
30
München
2024-10-01
Not yet open
Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol Use
NCT06256952Alcohol Use Disorder, Alcoholism, Stress Reaction, Ostracism
Charite University, Berlin, Germany
Not applicable
100
Berlin
2024-10-01
Recruiting
University Hospital, Geneva
Not applicable
220
Leipzig
2024-10-01
Recruiting
University Hospital, Bonn
Not applicable
50
Bonn
2024-10-01
Recruiting
The Effectiveness of Early Intervention to Correct the Position of PDC:s
NCT06267989Ectopic Tooth Eruption, Palatal Expansion Technique, Randomized Clinical Trial
Göteborg University
Not applicable
324
Traben-Trarbach
2024-10-01
Recruiting
ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos
NCT06920680Colorectal Cancer, Colonoscopy, Polypectomy
Wuerzburg University Hospital
Observational
1,834
Stuttgart, Würzburg
2024-10-01
Active, closed
Charite University, Berlin, Germany
Observational
30
Berlin
2024-10-01
Recruiting
Influence of Sarcopenia on the Course of the Diseases
NCT06829290Liver Cirrhosis, Cancer, Cachexia, Sarcopenia
Universitatsmedizin Mainz - 1. Medizinische Klinik
Observational
200
Mainz
2024-10-01
By invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
NCT06657859Pmm2-CDG, Phosphomannomutase 2 Deficiency
Glycomine, Inc.
Phase 2
90
Münster
2024-09-30
By invitation
Sanofi
Phase 2
900
Leipzig, Mainz
2024-09-30
Active, closed
Hannover Medical School
Not applicable
20
Heidelberg, Frankfurt am Main, Hanover, Berlin
2024-09-30
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Mannheim, Ulm, Augsburg, Eggenfelden, Erlangen, München, Regensburg, Rüdersdorf
2024-09-27
Recruiting
GlaxoSmithKline
Phase 2
393
Bochum, Berlin, Kiel, Leipzig, Mainz
2024-09-27
Active, closed
BioCryst Pharmaceuticals
Phase 1
76
Heidelberg
2024-09-26
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Ahrensburg, Bamberg, Berlin, Bonn, Coswig, Essen, Hamburg, Hanover
2024-09-26
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Böblingen, Homburg, Berlin, Erbach im Odenwald, Frankfurt am Main
2024-09-26
Recruiting
Hoffmann-La Roche
Observational
842
Aachen, Amberg, Arnsdorf, Aschaffenburg, Bad Soden, Bamberg, Berg, Berlin
2024-09-26
Recruiting
Takeda
Observational
500
Aachen
2024-09-25
Active, closed
Longboard Pharmaceuticals
Phase 3
108
Frankfurt am Main, Bielefeld, Bonn, Kiel, Ravensburg
2024-09-25
Active, closed
Genmab
Phase 3
699
Bonn, Dortmund, Dresden, Greifswald, Hamburg, Hanover, Mannheim, München
2024-09-25
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
Lexicon Pharmaceuticals
Phase 3
500
Berlin, Hamburg, Leipzig, München
2024-09-24
By invitation
Impact of Energy Density on Energy Intake During Bed Rest
NCT06571877Bed Rest, Space Analogue
University Hospital Tuebingen
Not applicable
48
Tübingen
2024-09-24
Active, closed
Nocion Therapeutics
Phase 2
455
Munich, Darmstadt, Frankfurt am Main, Marburg, Halle, Geesthacht, Lübeck, Berlin
2024-09-24
Active, closed
Hoffmann-La Roche
Phase 3
338
Berlin, Cologne, Essen, Esslingen am Neckar, Gauting, Großhansdorf, Heidelberg, Hemer
2024-09-23
Recruiting
Central Institute of Mental Health, Mannheim
Not applicable
162
Mannheim, Wiesloch
2024-09-23
Recruiting
Prospective WCD Post CABG Registry (CABG Registry)
NCT06570902Cardiomyopathy Ischemic, Cardiomyopathies, Cardiovascular Diseases, Heart Disease, Ischemic
Zoll Medical Corporation
Observational
910
Bad Nauheim, Hanover, Cottbus, Halle
2024-09-23
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Heidelberg, Erdgeschoss, Düsseldorf
2024-09-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Bonn, Göttingen, Hanover, Leipzig, Ludwigshafen am Rhein, Münster, Tübingen
2024-09-19
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
Eli Lilly and Company
Phase 1
340
Berlin, Essen, Frankfurt am Main
2024-09-19
Active, closed
argenx
Phase 3
141
Berlin, Göttingen
2024-09-18
Recruiting
AstraZeneca
Phase 1/2
174
Göttingen, München, Ulm, Würzburg
2024-09-18
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Freiburg im Breisgau, Ulm, Munich, Regensburg, Würzburg, Giessen, Buxtehude, Bochum
2024-09-18
Active, closed
Amgen
Phase 1
49
Essen, Heidelberg, Würzburg
2024-09-17
Recruiting
Pierre Fabre Medicament
Phase 1/2
171
Dresden
2024-09-17
Recruiting
University Hospital, Limoges
Not applicable
1,000
Hanover, Ulm
2024-09-17
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
NCT06866782Prostate Cancer, Advanced Prostate Cancer, Metastatic Prostate Cancer (mPC)
Fundacio Puigvert
Observational
600
Bonn, Hamburg, Munich, Planegg, Tübingen
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 4
500
Bochum, Göttingen, Hanover, Leipzig, Ulm
2024-09-17
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
München, Cologne
2024-09-17
Recruiting
Predicting Cancer Risk With Digital and Molecular Markers
NCT06962670Breast Cancer, Lung Cancer, Colorectal Cancer, Gynecologic Cancer
University of Erlangen-Nürnberg Medical School
Not applicable
1,250
Please Refer to Project Homepage For Details (see Link Below)
2024-09-14
Recruiting
Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure
NCT06556485Heart Failure, Arrhythmia, Ventricular, Cardiomyopathy Ischemic, Catheter Ablation
Heart and Diabetes Center North-Rhine Westfalia
Not applicable
160
Bad Oeynhausen
2024-09-13
Recruiting
University Hospital Schleswig-Holstein
Phase 2/3
459
Dornstadt, Heidelberg, Mannheim, Ulm, Augsburg, Bamberg, Dachau, Hamburg
2024-09-12
Active, closed
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06586515Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
Eli Lilly and Company
Phase 1
630
Berlin, Dresden, Essen, München
2024-09-12
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen
Phase 3
163
Aschaffenburg, Essen
2024-09-12
Recruiting
University Hospital Tuebingen
Not applicable
264
Tübingen
2024-09-11
Recruiting
GlaxoSmithKline
Phase 3
440
Essen, Minden, Mainz, Würzburg
2024-09-11
Active, closed
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
NCT06431373Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Priovant Therapeutics, Inc.
Phase 3
371
Mannheim, Bonn, Düsseldorf, Münster, Kiel, Mainz
2024-09-11
Active, closed
Noema Pharma AG
Phase 2
164
Düsseldorf, Hanover, Munich
2024-09-10
By invitation
DESI - Düsseldorfer ESD Study
NCT06993402Oesophageal Tumour, Gastric Tumours, Duodenal Tumours, Colon Tumours
Torsten Beyna
Observational
1,000
Düsseldorf
2024-09-10
Active, closed
GCP-Service International West GmbH
Phase 2
41
Düsseldorf, Leipzig, Münster
2024-09-10
Recruiting
Apnoeic Oxygenation During Pediatric Tracheal Intubation
NCT06576596Anesthesia, Airway Complication of Anesthesia, Anesthesia; Adverse Effect
University Hospital Heidelberg
Not applicable
200
Heidelberg
2024-09-09
By invitation
Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
NCT06605612Inclusion Body Myositis, Myotonic Dystrophy, Limb-girdle and Facioscapulohumeral Muscular Dystrophies, Pompe Disease
LMU Klinikum
Observational
108
München
2024-09-09
Active, closed
Amgen
Phase 3
315
Essen, Hösbach, Landshut, Neumünster
2024-09-09
Recruiting
University of Kiel
Not applicable
60
Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte
2024-09-05
Recruiting
STIMPulseControl Ancillary Speech Study
NCT06561919Parkinson Disease, Impulse Control Disorder
Steffen Paschen
Not applicable
60
Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte
2024-09-05
Recruiting
AbbVie
Phase 2
590
Freiburg im Breisgau, Mannheim, Ulm, Erlangen, Munich, Regensburg, Frankfurt am Main, Fulda
2024-09-04
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Stuttgart, Frankfurt am Main, Cologne, Leipzig, Jena, Essen, Lübeck, Mainz
2024-09-04
Active, closed
Takeda
Phase 3
2,099
Blankenfelde-Mahlow, Bad Bentheim, Oldenburg, Dresden, Gera, Hamburg
2024-09-04
Recruiting
Aresus Pharma GmbH
Phase 3
280
Strausberg
2024-09-04
Active, closed
Tectonic Therapeutic
Phase 2
191
Mainz
2024-09-04
Recruiting
Novartis Pharmaceuticals
Observational
500
Konstanz, Stuttgart, Munich, Regensburg, Würzburg, Cottbus, Frankfurt (Oder), Ludwigshafen
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Cologne, Dresden, Giessen, Heidelberg, Munich, München, Würzburg
2024-09-03
Recruiting
ATLAS (AltaValve) Pivotal Trial
NCT06465745Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation
4C Medical Technologies, Inc.
Not applicable
450
Berlin, Bonn, Cologne, Dortmund, Mainz, Oeynhausen, Trier, Ulm
2024-09-03
By invitation
Guidelines on Long-term Medical Fasting
NCT06748027Fasting Period, Fasting
Charite University, Berlin, Germany
Observational
60
Berlin
2024-09-02
By invitation
B-challenged: Co-creating Physical and Social Environments to Promote Children's Active Outdoor Play
NCT07136376Active Outdoor Play and Related Healthy Dietary Behaviours
Amsterdam UMC, location VUmc
Not applicable
850
Bremen
2024-09-01
Recruiting
Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease
NCT06523608Liver Diseases, Hepatocellular Carcinoma, Hepatocarcinoma, Advanced Chronic Liver Disease
University Hospital Muenster
Observational
600
Münster
2024-09-01
Active, closed
Charite University, Berlin, Germany
Observational
932,912
Berlin
2024-09-01
Recruiting
Parenting with an Autism Spectrum Disorder
NCT06502054Autism Spectrum Disorder
Universitätsklinikum Hamburg-Eppendorf
Observational
184
Hamburg
2024-09-01
Recruiting
CRS Questionnaire Validation Project
NCT06970977Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
The European Forum for Research and Education in Allergy and Airway Diseases
Observational
1,000
Düsseldorf, Munich
2024-09-01
Recruiting
Charite University, Berlin, Germany
Not applicable
60
Berlin
2024-09-01
Recruiting
University of Rostock
Phase 2/3
164
Rostock
2024-09-01
Recruiting
Liquid Biopsy Under PSMA Radioligand Therapy
NCT07118436Prostate Cancer Metastatic Castration-Resistant, Prostate Cancer
Wuerzburg University Hospital
Observational
100
Augsburg, München, Würzburg
2024-09-01
Not yet open
University Hospital of Cologne
Not applicable
60
Cologne
2024-09-01
Recruiting
Progression Assessment of PXE-associated Alterations
NCT07048106Pseudoxanthoma Elasticum, Angioid Streaks, Peau d'Orange, Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)
University Hospital, Bonn
Observational
100
Bonn
2024-09-01
Recruiting
University of Giessen
Not applicable
1,057
Giessen
2024-09-01
Not yet open
The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.
NCT06295094Gastric Cancer, Chemotherapy, Adjuvant, Peritoneal Metastases, Minimally Invasive Surgical Procedures
Odense University Hospital
Phase 2
264
Berlin
2024-09
Recruiting
Alimera Sciences
Phase 4
25
Berlin, Münster
2024-08-31
Recruiting
Dr. Inge Winter
Phase 3
418
Bielefeld, Dortmund, Frankfurt am Main, Münster
2024-08-31
Recruiting
ReAlta Life Sciences, Inc.
Phase 2
66
Freiburg im Breisgau
2024-08-31
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Aachen, Berlin, Dresden, Leipzig
2024-08-30
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Aachen, Bad Kreuznach, Bad Nenndorf, Bad Oeynhausen, Berlin, Bonn, Braunschweig, Cloppenburg
2024-08-30
Recruiting
Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma
NCT06175845Cholangiocarcinoma, Klatskin Tumor, Bile Duct Cancer, Liver Cancer
Universitätsklinikum Hamburg-Eppendorf
Not applicable
130
Berlin, Bonn, Chemnitz, Essen, Hamburg, Hanover, Heidelberg, Lübeck
2024-08-30
Active, closed
Central Institute of Mental Health, Mannheim
Phase 2
98
Mannheim
2024-08-29
Recruiting
The TRICURE EU Pivotal Study
NCT06581471Tricuspid Valve Regurgitation, Heart Valve Disease, Cardiovascular Diseases
TRiCares
Not applicable
80
Mainz, Munich
2024-08-29
Active, closed
Sanofi
Phase 2
229
Berlin, Halle, Mainz
2024-08-29
Recruiting
Kyverna Therapeutics
Phase 2/3
66
Berlin, Bochum, Hamburg, Hanover, Jena, Magdeburg, Munich
2024-08-28
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
AstraZeneca
Phase 2
120
Berlin, Potsdam, Ulm
2024-08-28
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
NCT06351592Amyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals
Phase 1/2
54
Ulm
2024-08-28
Recruiting
Bayer
Phase 3
444
Stuttgart, Nuremberg, Frankfurt am Main, Giessen, Cologne, Essen, Hemer, Berlin
2024-08-28
Active, closed
Gilead Sciences
Phase 3
640
Bad Homburg, Düsseldorf, Essen, Hamburg, Hanover, Leipzig, München, Ulm
2024-08-28
Recruiting
Prevail Therapeutics
Phase 1
124
Düsseldorf, Münster
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
204
Berlin, Dresden, Giessen, Göttingen
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
132
Berlin, Dresden, Giessen, Göttingen
2024-08-27
Recruiting
Observational Study of Venus P-Valve
NCT05835349Right Ventricular Outflow Tract Dysfunction
Venus MedTech (HangZhou) Inc.
Observational
200
Munich, Berlin
2024-08-26
Active, closed
Regeneron Pharmaceuticals
Phase 4
120
Augsburg, Munich, Frankfurt am Main, Koblenz, Lübeck, Berlin, Leipzig, Mainz
2024-08-26
Active, closed
Kite, A Gilead Company
Phase 3
452
Berlin, Cologne, Essen, Freiburg im Breisgau, Hamburg, Leipzig, München, Tübingen
2024-08-23
Recruiting
University of Cologne
Phase 2
20
Stuttgart, Freiburg im Breisgau, Cologne, Hamburg, Essen, Berlin
2024-08-23
Recruiting
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extra- and Intrahepatic Cholangiocarcinoma
NCT06440993Extrahepatic Cholangiocarcinoma, Unresectable Perihilar or Ductal CCA
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
42
Aachen, Bonn, Cologne, Düsseldorf, Frankfurt, Göttingen, Hanover, Lübeck
2024-08-23
Recruiting
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
NCT05843253High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma
Nationwide Children's Hospital
Phase 2
120
Heidelberg
2024-08-22
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
NCT06535607Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
AstraZeneca
Phase 2
257
Cologne, Frankfurt, Gauting, Großhansdorf, Hamburg, Heidelberg, Mainz, Münster
2024-08-22
Recruiting
Heart and Diabetes Center North-Rhine Westfalia
Not applicable
250
Bad Oeynhausen
2024-08-21
Recruiting
Abbott Structural Heart Device Registry
NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale
Abbott Medical Devices
Observational
2,500
München, Bremen, Jena, Braunschweig, Berlin, Bad Rothenfelde
2024-08-21
Recruiting
Sanofi
Phase 3
160
Berlin, Bochum, Bremen, Essen, Göttingen, Hanover, Homburg, Münster
2024-08-21
Active, closed
Extra Wide Field of View Lens Study
NCT06483503Colonic Polyp
Pentax Medical
Observational
60
Düsseldorf
2024-08-21
Recruiting
Estradiol and Intrusive Memories
NCT07419594PTSD, Intrusive Memories, Intrusion Symptom, Trauma
Charite University, Berlin, Germany
Not applicable
273
Berlin
2024-08-19
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Tübingen, Erlangen, Rüdersdorf, Sachsen, Göttingen, Lübeck
2024-08-19
Recruiting
CABP2 Patient Registry and Natural History Study
NCT06680934CABP2-related Auditory Synaptopathy, Hearing Impairment
University Medical Center Goettingen
Observational
100
Göttingen
2024-08-16
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
Merck Sharp & Dohme LLC
Phase 1/2
90
Tübingen, Cologne, Münster, Berlin
2024-08-16
Recruiting
Charite University, Berlin, Germany
Observational
25
Hanover, Düsseldorf, Berlin
2024-08-16
Recruiting
Technical University of Munich
Observational
100
München
2024-08-15
Recruiting
One-Month DAPT in CABG Patients
NCT05997693Chronic Coronary Disease
Weill Medical College of Cornell University
Phase 3
700
Düsseldorf, Essen, Freiburg im Breisgau, Giessen, Jena, München, Stuttgart
2024-08-15
By invitation
University Hospital Augsburg
Not applicable
10
Augsburg
2024-08-13
Recruiting
AstraZeneca
Phase 3
620
Berlin, Bonn, Cologne, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg
2024-08-12
Recruiting
MB-CART19.1 in Refractory SLE
NCT06189157SLE - Systemic Lupus Erythematosus
Miltenyi Biomedicine GmbH
Phase 1/2
29
Erlangen, Magdeburg, Tübingen
2024-08-12
Recruiting
BSN Medical GmbH
Not applicable
152
Melle
2024-08-10
Recruiting
Fraunhofer-Institute of Toxicology and Experimental Medicine
Not applicable
15
Hanover
2024-08-09
Active, closed
Incyte Corporation
Phase 1
37
Aachen, Essen, Halle
2024-08-08
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
Alimentiv Inc.
Phase 4
304
Augsburg, Frankfurt am Main, Lüneburg, Kiel, Freiburg im Breisgau
2024-08-07
Recruiting
Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
NCT07515508Cardiogenic Shock, Acute Heart Failure (AHF)
University Heart Center Freiburg - Bad Krozingen
Observational
600
Bad Krozingen, Freiburg im Breisgau, Nuremberg, Villingen-Schwenningen
2024-08-07
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Frankfurt, Hanover, München, Münster
2024-08-07
Recruiting
AstraZeneca
Phase 3
1,018
Berlin, Deggendorf, Düsseldorf, Göttingen, Hamburg, Heidelberg, Jena, Karlsruhe
2024-08-07
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
210
Heidelberg, Erdgeschoss, Düsseldorf
2024-08-07
Recruiting
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
NCT06212193Tricuspid Regurgitation, Tricuspid Regurgitation Functional
Innoventric LTD
Not applicable
25
Mainz, Leipzig
2024-08-05
Active, closed
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Novartis Pharmaceuticals
Phase 2
84
Kirchheim unter Teck, Munich, Ludwigshafen, Berlin, Mainz
2024-08-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Essen, Dresden, Hohenmölsen, Bad Berka, Berlin
2024-08-05
Recruiting
Role of Pavlovian Mechanisms for Control Over Substance Use
NCT06701487Alcohol Use Disorder (AUD), Alcoholism, Substance Use Disorders, Cannabis Use Disorder
Technische Universität Dresden
Observational
200
Dresden
2024-08-05
Recruiting
Hannah Schaefer
Observational
100
Munich
2024-08-05
Recruiting
Targeted Pediatric High-Grade Glioma Therapy
NCT05839379High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Glioblastoma
Nationwide Children's Hospital
Observational
350
Heidelberg
2024-08-02
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Not applicable
40
Hamburg
2024-08-01
Recruiting
Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis
NCT06389968Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
Technical University of Munich
Not applicable
50
Munich
2024-08-01
Recruiting
Dr. Inge Winter
Phase 4
418
Augsburg, Bielefeld, Dortmund, Frankfurt am Main, Mainz, Münster
2024-08-01
By invitation
Buchinger Wilhelmi Development & Holding GmbH
Observational
300
Überlingen
2024-08-01
Active, closed
Study Protocol for a Pilot Randomized Controlled Trial of a Psychosocial Care Intervention in Intensive Care
NCT06733493Psychosocial Intervention, Intensive Care Units (ICUs), Psychosocial Health
Harald Gündel
Not applicable
375
Ulm, Magdeburg, Berlin
2024-08-01
By invitation
University Hospital, Bonn
Not applicable
12
Bonn
2024-08-01
Recruiting
Firalis SA
Observational
4,100
Lübeck, Mainz-GE
2024-08-01
Active, closed
GlaxoSmithKline
Phase 3
10,212
Weinheim, Dachau, Munich, Hanover, Cologne, Essen, Goch, Freiberg
2024-08-01
Recruiting
Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension
NCT06291714Intraoperative Hypotension, Acute Kidney Injury, Myocardial Injury After Non-cardiac Surgery
University of Giessen
Not applicable
150
Giessen
2024-08-01
Recruiting
Zentralklinik Bad Berka
Observational
5,000
Bad Berka
2024-08-01
Recruiting
Wuerzburg University Hospital
Observational
200
Würzburg, Jena
2024-08-01
By invitation
University Hospital Goettingen
Observational
100
Göttingen
2024-08
Recruiting
University Medical Center Groningen
Phase 3
300
Berlin, Cologne, Dresden, Leipzig
2024-07-31
Recruiting
NovoCure GmbH
Phase 3
734
Berlin, Giessen, Halle, Heidelberg, Löwenstein, Oldenburg
2024-07-31
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Essen, Bottrop, Dresden, Leipzig, Mönchengladbach, München, Münster, Wolfsburg
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Munich, Regensburg, Würzburg, Frankfurt am Main, Bochum, Essen
2024-07-31
By invitation
AOP Orphan Pharmaceuticals AG
Observational
110
Berlin, Dresden, Greifswald
2024-07-31
By invitation
Wuerzburg University Hospital
Not applicable
64
Würzburg
2024-07-31
Recruiting
AUTONOMOUS DISORDERS IN CMT
NCT07570446CMT - Charcot-Marie-Tooth Disease, CMT1A, CMT (Charcot Marie Tooth Disease)
University Medical Center Goettingen
Observational
50
Göttingen
2024-07-30
Recruiting
TREMOR IN CHARCOT-MARIE-TOOTH
NCT07570459CMT, CMT (Charcot Marie Tooth Disease), Charcot Marie Tooth Disease (CMT), Charcot Marie Tooth Disease
University Medical Center Goettingen
Observational
75
Göttingen
2024-07-30
By invitation
Viatris Innovation GmbH
Phase 3
680
Leipzig, Minden
2024-07-30
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Freiburg im Breisgau, Kehl, Ulm, Erlangen, München, Bernau bei Berlin, Marburg, Osnabrück
2024-07-30
Active, closed
Novartis Pharmaceuticals
Phase 1
31
München, Rostock
2024-07-29
Active, closed
UCB Biopharma SRL
Phase 3
89
Berlin, Frankfurt am Main, Freiburg im Breisgau
2024-07-29
Recruiting
AstraZeneca
Observational
300
Ahrensburg, Ansbach, Aschaffenburg, Auerbach, Augsburg, Bad Homburg, Berlin, Cottbus
2024-07-25
Recruiting
University of Kiel
Not applicable
42
Kiel
2024-07-25
Recruiting
Universität Münster
Observational
257
Münster
2024-07-24
Active, closed
Ferrer Internacional S.A.
Phase 2
241
Beelitz, Düsseldorf, Leipzig, Munich
2024-07-23
Recruiting
PulseSelect™ PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Frankfurt, Heidelberg, Ludwigshafen am Rhein, Paderborn
2024-07-23
Active, closed
OncoVerity, Inc.
Phase 2
140
Düsseldorf, Frankfurt, Kiel
2024-07-22
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Aachen, Cologne, Homburg, Münster
2024-07-22
Active, closed
MedSIR
Phase 2
165
Bottrop, Essen, Hamburg, München
2024-07-22
Recruiting
Wave Life Sciences USA, Inc.
Phase 1/2
48
Aachen
2024-07-19
Active, closed
University Hospital Tuebingen
Not applicable
120
Tübingen
2024-07-19
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Freiburg im Breisgau, Heidelberg, Tübingen, München, Frankfurt am Main, Hanover, Dresden, Lübeck
2024-07-19
Recruiting
Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion
NCT07342036Tricuspid Valve Regurgitation, Pacemaker, ICD, Left Bundle Branch Area Pacing
Hazem Omran
Observational
200
Bad Oeynhausen
2024-07-19
Active, closed
Celldex Therapeutics
Phase 3
976
Aachen, Bad Bentheim, Berlin, Bonn, Dresden, Düsseldorf, Essen, Hamburg
2024-07-19
Recruiting
GlaxoSmithKline
Phase 3
150
Bonn, Frankfurt
2024-07-19
Recruiting
Fresenius Medical Care Deutschland GmbH
Not applicable
46
Aschaffenburg, Munich, Braunschweig, Paderborn, Berlin, Ulm, Würzburg
2024-07-18
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Berlin, Dachau, Duisburg, Frankfurt am Main, Halle, Heidelberg, Kiel, Leipzig
2024-07-18
Recruiting
Amgen
Phase 3
450
Berlin, Chemnitz, Dresden, Essen, Frankfurt am Main, Hamburg, Ludwigsburg, München
2024-07-17
Recruiting
Hannover Medical School
Not applicable
756
Ludwigsburg, Tübingen, Bad Homburg, Göttingen, Hanover, Lüneburg, Bielefeld, Düsseldorf
2024-07-17
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Immenhausen, Essen, Großhansdorf, Esslingen am Neckar, Giessen, Hamburg, Hemer, Neuss
2024-07-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Landshut, Hanover, Aachen, Essen, Mainz, Halle, Jena, Berlin
2024-07-16
Recruiting
Heidelberg University
Observational
4,000
Bochum, Bonn, Dresden, Erlangen, Essen, Göttingen, Heidelberg, Kiel
2024-07-16
Active, closed
Cardiovascular and Interventional Radiological Society of Europe
Observational
400
Cologne, Essen, Hanover, Heilbronn, Karlsruhe, Mülheim, Neumünster, Rendsburg
2024-07-15
Recruiting
Pamgene International B.V.
Observational
196
Tübingen, Heidelberg, München
2024-07-12
Recruiting
Philogen S.p.A.
Phase 2
162
Essen, Freiburg im Breisgau, Kiel, Tübingen
2024-07-12
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Bad Homburg, Berlin, Bochum, Essen, Giessen, Tübingen
2024-07-12
Active, closed
Celldex Therapeutics
Phase 3
963
Langenau, Darmstadt, Löhne, Dülmen, Kiel, Berlin, Bramsche, Mainz
2024-07-11
Recruiting
Replimune, Inc.
Phase 3
400
Berlin, Dresden, Erfurt, Essen, Hamburg, Heidelberg, Kiel, Mainz
2024-07-11
Recruiting
AO Innovation Translation Center
Observational
76
Freiburg im Breisgau, Münster
2024-07-10
Recruiting
University Hospital Tuebingen
Phase 1
52
Tübingen
2024-07-10
Recruiting
Bielefeld University
Not applicable
40
Bielefeld, Marburg
2024-07-09
Recruiting
Marc Donath
Phase 2
300
Düsseldorf
2024-07-09
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Servier Bio-Innovation LLC
Phase 3
156
Bad Saarow, Berlin, Dresden, Hamburg, Mannheim, München, Münster, Ulm
2024-07-09
Recruiting
Adolescent Psychiatry Inpatients: Self-reported Parent-adolescent Communication Quality and Treatment Outcome
NCT06633458Mental Disorder in Adolescence, Depression in Adolescence, Anxiety
Universitätsklinikum Hamburg-Eppendorf
Observational
60
Hamburg
2024-07-08
Recruiting
University Hospital Tuebingen
Not applicable
120
Stuttgart
2024-07-08
Recruiting
Combination of Hypothermia and Thrombectomy in Acute Stroke
NCT06301412Ischemic Stroke, Large Vessel Occlusion, Endovascular Treatment
University of Freiburg
Phase 3
400
Freiburg im Breisgau
2024-07-07
Recruiting
Multi-biomarkers in DEE
NCT07909382Developmental and Epileptic Encephalopathies (DEE)
Istituto Giannina Gaslini
Observational
200
Heidelberg
2024-07-04
Recruiting
University Hospital, Basel, Switzerland
Not applicable
498
Bad Krozingen, Bad Nauheim, Bad Oeynhausen, Giessen, Kiel
2024-07-04
Recruiting
AO Innovation Translation Center
Observational
600
Frankfurt, Giessen, Heidelberg, Münster, Wildeshausen
2024-07-03
Recruiting
Comparative Study of Navigation-assisted OrthoPilot® Elite and Robotic-assisted MAKO® Total Knee Arthroplasty
NCT05980442Osteoarthritis, Knee, Joint Diseases, Rheumatoid Arthritis of Knee, Posttraumatic Arthropathy
Aesculap AG
Observational
140
Ulm
2024-07-03
Active, closed
Ultra-high-caloric, Fatty Diet in ALS
NCT06280079Amyotrophic Lateral Sclerosis
University of Ulm
Not applicable
399
Aachen, Berlin, Bochum, Bonn, Dresden, Erlangen, Essen, Göttingen
2024-07-02
Recruiting
Semibranch Registry - Retrospective
NCT06374355Aortic Aneurysm, Endovascular Aortic Repair, Stent-Graft Endoleak
University Hospital Muenster
Observational
100
Münster
2024-07-02
Recruiting
Jena University Hospital
Observational
74
Jena
2024-07-01
Recruiting
AI-POD Clinical Validation Study for Obese Patients
NCT06595134Acute Cardiovascular Disease
University Hospital, Bonn
Observational
1,200
Bonn, Mannheim
2024-07-01
Recruiting
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
NCT06487832Normal Weight, Overweight and Obesity, Insulin Sensitivity, Insulin Resistance
University Hospital Tuebingen
Not applicable
60
Tübingen
2024-07-01
Active, closed
Johannes Gutenberg University Mainz
Not applicable
1,354
Homburg, Mainz
2024-07-01
Recruiting
European Foundation for Study of Chronic Liver Failure
Phase 2
90
Aachen, Münster
2024-07-01
Recruiting
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT06102057Stage III Non-small Cell Lung Cancer, Locally Advanced, Unresectable
TheraOp
Phase 2
110
Dresden, Essen, Freiburg im Breisgau, Göttingen, Homburg, Mönchengladbach, München, Oldenburg
2024-07-01
Not yet open
Technische Universität Dresden
Phase 2
276
Freiburg im Breisgau, Heidelberg, Mannheim, Würzburg, Dresden, Leipzig, Berlin, München
2024-07-01
Recruiting
Deutsches Herzzentrum Muenchen
Not applicable
666
Heidelberg, Mannheim, Singen, Ulm, Augsburg, Dachau, Erding, Ingolstadt
2024-07-01
Recruiting
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
NCT07777744Ventricular Tachycardia (VT), Premature Ventricular Complexes
University Hospital, Basel, Switzerland
Observational
15,000
Bad Berka, Bad Krozingen, Cottbus, Münster
2024-07-01
Recruiting
Evaluation of Arthroplasty Treatment
NCT07799818Surgery, Knee Arthropathy, Hip Arthropathy, Prosthetic-joint Infection
University Hospital, Bonn
Observational
300
Bonn
2024-07-01
Recruiting
Cardioangiologisches Centrum Bethanien
Observational
200
Berlin, Frankfurt am Main
2024-07-01
Recruiting
Technical University of Munich
Not applicable
120
Munich
2024-07-01
Not yet open
European Society of Anaesthesiology
Observational
8,250
Düsseldorf
2024-06-30
Active, closed
AstraZeneca
Phase 3
339
Berlin, Bochum, Dresden, Erlangen, Essen, Freiburg im Breisgau, Hanover, Kiel
2024-06-29
Recruiting
AstraZeneca
Observational
600
Bad Homburg, Berlin, Bremen, Celle, Chemnitz, Cologne, Deggendorf, Frankfurt
2024-06-28
Recruiting
argenx
Phase 2/3
12
Essen
2024-06-28
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Freiburg im Breisgau, Würzburg, Berlin, Herne
2024-06-28
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Aachen, Greifswald, Halle, Rostock
2024-06-28
Recruiting
Intensity Therapeutics, Inc.
Phase 3
333
Bad Saarow, Leipzig
2024-06-28
Recruiting
Boehringer Ingelheim
Phase 1/2
910
Dresden, Erlangen, Essen, Hamburg, Mannheim, Ulm
2024-06-28
Recruiting
IRCCS Sacro Cuore Don Calabria di Negrar
Not applicable
278
Hamburg
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Freiburg im Breisgau, Tübingen, Erlangen, Memmingen, Darmstadt, Bad Bentheim, Rostock, Bochum
2024-06-27
Recruiting
Infertility Treatment Center Dortmund
Observational
2,400
Dortmund
2024-06-26
Recruiting
Non Interventional German Leptomeningeal Disease Register
NCT06146010Meningeal Neoplasms, Leptomeningeal Disease
University Hospital Tuebingen
Observational
50
Bonn, Mannheim, München, Münster, Siegen, Tübingen, Ulm
2024-06-26
Recruiting
A Registry-study of ELZONRIS in Participants With BPDCN
NCT07785154Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
80
Augsburg, Bielefeld, Chemnitz, Frankfurt, Freiburg im Breisgau, Halle, Hamburg, Kiel
2024-06-26
Active, closed
Genmab
Phase 3
621
Berlin, Dresden, Essen, Giessen, Greifswald, Hanover, Leipzig, München
2024-06-25
Active, closed
UCB Biopharma SRL
Phase 3
176
Bad Bentheim, Berlin, Bonn, Dresden, Erlangen, Frankfurt am Main, Hamburg, Kiel
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bad Berka, Berlin, Bielefeld, Bremen, Cologne, Dachau, Dortmund, Dresden
2024-06-25
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
NCT06465810Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR
AstraZeneca
Observational
1,850
Würzburg, Frankfurt am Main, Hanover, Aachen, Cologne, Mainz, Homburg, Berlin
2024-06-25
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Ulm, Göttingen, Hanover, Bochum, Düsseldorf, Dresden, Leipzig, Lübeck
2024-06-25
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
20
Erlangen
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Freiburg im Breisgau, Ludwigsburg, Tübingen, Erlangen, Munich, Potsdam, Georgsmarienhütte, Hanover
2024-06-24
Recruiting
Spinal CSF Leaks in Chronic Subdural Hematoma
NCT06323434Chronic Subdural Hematoma
University of Freiburg
Observational
220
Freiburg im Breisgau
2024-06-24
Recruiting
Cera™ Vascular Plug System Post-Market Clinical Follow-Up
NCT06099015Aneurysm, Endoleak, Pulmonary Arteriovenous Malformation, Portal Hypertension
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
132
Bad Hersfeld
2024-06-21
Recruiting
Heinrich-Heine University, Duesseldorf
Observational
77
Düsseldorf
2024-06-20
Recruiting
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
NCT06526065DLBCL - Diffuse Large B Cell Lymphoma
University Medical Center Goettingen
Observational
500
Göttingen
2024-06-20
Active, closed
Max Planck Social Neuroscience Lab
Not applicable
200
Berlin
2024-06-20
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Heidelberg, Mannheim, Tübingen, Regensburg, Bonn, Chemnitz, Leipzig, Berlin
2024-06-19
Active, closed
Celgene
Phase 3
850
Ulm, Augsburg, Bayreuth, Erlangen, Langen, Hanover, Koblenz, Halle
2024-06-19
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
60
München, Ulm
2024-06-19
Recruiting
University Hospital Freiburg
Not applicable
50
Freiburg im Breisgau
2024-06-18
Recruiting
Managing Congestion in Heart Failure: A Mechanistic Study in Patients With HFpEF
NCT06977477Heart Failure With Preserved Ejection Fraction, Remote Monitoring in Heart Failure
Otto-von-Guericke University Magdeburg
Not applicable
20
Magdeburg
2024-06-18
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
10
Erlangen
2024-06-18
Active, closed
BioMarin Pharmaceutical
Phase 3
80
Cologne, Magdeburg
2024-06-17
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Aachen, Bad Friedrichshall, Berlin, Bonn, Dessau, Dresden, Erfurt, Frankfurt
2024-06-17
Active, closed
Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)
NCT06723418Inflammatory Bowel Diseases (IBD), Crohns Disease, Ulcerative Colitis (UC)
University of Glasgow
Observational
2,000
Giessen
2024-06-15
Active, closed
Extended Validation of Donor-derived Cell-free DNA in Kidney Transplant Recipients
NCT07805343Rejection Acute Renal, Rejection Chronic Renal, Transplantation, Kidney Rejection Transplant
Paris Translational Research Center for Organ Transplantation
Observational
5,000
Berlin
2024-06-15
Recruiting
Heinrich-Heine University, Duesseldorf
Observational
150
Düsseldorf
2024-06-15
Active, closed
Hannover Medical School
Phase 4
44
Hanover
2024-06-14
Recruiting
ABX advanced biochemical compounds GmbH
Phase 3
434
Dresden, Düsseldorf, Gronau, Hamburg, Leipzig, München, Münster, Rostock
2024-06-13
Recruiting
Gilead Sciences
Phase 1/2
334
Berlin, Cologne
2024-06-12
Active, closed
Novartis Pharmaceuticals
Observational
116
Hamburg, Lingen, Koblenz, Leipzig, Halle, Ahaus, Berlin, Bremen
2024-06-11
Active, closed
AskBio Inc
Phase 2
59
Berlin, Marburg, Tübingen, Würzburg
2024-06-11
Recruiting
University Hospital Tuebingen
Phase 1
20
Tübingen
2024-06-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Dortmund, Essen, Lübeck, Gera, Berlin
2024-06-10
Recruiting
LEO Pharma
Phase 3
195
Buxtehude, Dresden, Mainz, Osnabrück, Tübingen, Wuppertal
2024-06-10
Recruiting
Dr. Falk Pharma GmbH
Phase 2
356
Mainz
2024-06-10
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Chemnitz, Hamburg, Heidelberg, Würzburg
2024-06-07
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Amberg, Bamberg, Berlin, Bremen, Chemnitz, Düsseldorf, Frankfurt, Freiburg im Breisgau
2024-06-07
Active, closed
GlaxoSmithKline
Phase 4
302
Mainz, Herne, Lübeck, Meerbusch
2024-06-06
Recruiting
University Hospital, Basel, Switzerland
Phase 2
75
Freiburg im Breisgau, Würzburg
2024-06-06
Recruiting
Boris Böll
Observational
400
Cologne, Dessau, Essen, Frankfurt am Main, Leipzig, Magdeburg
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Pforzheim, München, Ulm, Hanover, Lüneburg, Rostock, Cologne, Duisburg
2024-06-05
Recruiting
Immunocore Ltd
Phase 3
680
Berlin, Bremen, Dortmund, Dresden, Erfurt, Erlangen, Essen, Frankfurt
2024-06-05
Active, closed
Amgen
Phase 3
563
Cologne, Dresden, Essen, Gauting, Großhansdorf, Heidelberg, Münster, Würzburg
2024-06-05
Recruiting
Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
NCT06472557Spinocerebellar Ataxia Type 27B
University Hospital Tuebingen
Observational
300
Tübingen, Essen
2024-06-04
Recruiting
Eli Lilly and Company
Phase 3
300
Cologne, Leipzig, Ulm
2024-06-03
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Düsseldorf, Freiburg im Breisgau, Halle, Hamburg, Hanover, Heidelberg, Jena, Kiel
2024-06-03
Recruiting
Lohmann & Rauscher
Observational
110
Berlin, Mannheim, Munich, Münster, Rheine, Tübingen
2024-06-03
Recruiting
University Hospital, Bordeaux
Not applicable
192
München
2024-06-03
Recruiting
Curasight
Phase 2
168
Chemnitz, Düsseldorf, Hamburg, Munich
2024-06-01
Recruiting
University Hospital Tuebingen
Observational
225
Tübingen
2024-06-01
Recruiting
University Hospital, Essen
Not applicable
30
Essen
2024-06-01
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
100
Erlangen
2024-06-01
Recruiting
Long-term Follow-up of Children Born in the PETN Studies
NCT06534307Intrauterine Growth Restriction, Pentaerithrityl Teratnitrate in Pregnancy, Long-Term Effects to Children
Jena University Hospital
Observational
228
Tübingen, Ulm, München, Hanover, Bonn, Dresden, Leipzig, Halle
2024-06-01
Recruiting
Wuerzburg University Hospital
Not applicable
52
Würzburg
2024-06-01
Recruiting
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
NCT07016477Coronary Artery Disease, Aortic Valve Stenosis, Tomography, X-Ray Computed
Semmelweis University
Observational
1,000
Freiburg im Breisgau, Mainz, Tübingen
2024-06-01
Recruiting
Association Between Biomarkers and Kidney Function Decline in Pulmonary Hypertension
NCT06409624Pulmonary Hypertension, Chronic Kidney Disease
University of Giessen
Observational
400
Bad Nauheim, Giessen
2024-05-31
Recruiting
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
103
Freiburg im Breisgau
2024-05-30
Active, closed
Stealth BioTherapeutics Inc.
Phase 3
313
Münster, Regensburg, Tübingen
2024-05-30
Active, closed
Amgen
Phase 1/2
94
Essen, Frankfurt am Main, Freiburg im Breisgau, Leipzig
2024-05-30
By invitation
Deutsches Herzzentrum Muenchen
Observational
250
Munich
2024-05-28
Recruiting
Philipps University Marburg
Not applicable
40
Marburg
2024-05-28
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Essen
2024-05-28
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Hoffmann-La Roche
Phase 3
1,800
Chemnitz, Frankfurt, Freiburg im Breisgau, Hanover, Homburg, Münster
2024-05-24
Active, closed
The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients
NCT07126860Prostate Cancer, Metastatic Prostate Cancer, Prostate Cancer (Post Prostatectomy), Prostate Cancer Patients Treated by Radiotherapy
Ludwig-Maximilians - University of Munich
Not applicable
150
Munich
2024-05-24
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Bayreuth, Böblingen, Erbach im Odenwald, Ulm
2024-05-24
Recruiting
University of Cologne
Phase 2
120
Cologne
2024-05-24
Active, closed
Analysis of TPE Treatments With multiFiltratePRO
NCT06272084Autoimmune Diseases
Fresenius Medical Care Deutschland GmbH
Observational
60
Aschaffenburg, Würzburg, Berlin
2024-05-22
By invitation
University of Bonn
Not applicable
80
Bonn
2024-05-21
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Cologne, Leipzig
2024-05-21
Recruiting
Daiichi Sankyo
Phase 3
540
Berlin, Erfurt, Essen, Frankfurt, Frankfurt am Main, Gauting, Gera, Giessen
2024-05-21
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
220
Heidelberg, Tübingen, Munich, Berlin, Hamburg
2024-05-20
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Frankfurt am Main, Cologne, Berlin
2024-05-20
Active, closed
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Berlin, Essen, Heidelberg
2024-05-20
Active, closed
AbbVie
Phase 3
421
Freiburg im Breisgau, Karlsruhe, Chemnitz, Berlin, Frankfurt am Main, Hamburg
2024-05-19
Active, closed
Heinrich-Heine University, Duesseldorf
Observational
55
Düsseldorf
2024-05-17
Recruiting
Hearing and Structure Preservation Via ECochG
NCT06268340Hearing Loss, Sensorineural, Severe-to-profound Hearing Loss
Advanced Bionics AG
Not applicable
102
Freiburg im Breisgau
2024-05-15
Recruiting
Bayer
Observational
50,000
Berlin
2024-05-15
Recruiting
Boehringer Ingelheim
Phase 2
175
Bonn, Mainz, Neubrandenburg, Tübingen, Ulm
2024-05-15
Active, closed
Novartis Pharmaceuticals
Phase 1
42
Essen, München
2024-05-15
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Augsburg, Düsseldorf, Essen, Heidelberg, Lübeck
2024-05-15
Recruiting
Corheart 6 LVAS Study
NCT05876000Refractory Heart Failure
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
53
Bad Oeynhausen, Berlin, Bremen, Hamburg, Heidelberg, Leipzig, Würzburg
2024-05-14
Active, closed
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System
NCT05540223Coronary Artery Disease, Atherosclerosis, Coronary, Myocardial Ischemia, Ischemic Heart Disease
Biotronik AG
Not applicable
1,861
Neuss
2024-05-13
Recruiting
University Hospital, Bonn
Not applicable
90
Bonn
2024-05-13
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Freiburg im Breisgau, Kehl, Ulm, Erlangen, Bernau bei Berlin, Marburg, Osnabrück, Bielefeld
2024-05-13
Not yet open
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
NCT04889742Recurrent Cancer, Prostate Cancer, Cervical Cancer, Anal Cancer
Charite University, Berlin, Germany
Phase 2
110
Berlin
2024-05-10
Recruiting
Essen Amyloidosis Registry
NCT06887283Amyloidosis; Systemic, Amyloidosis Cardiac
University Hospital, Essen
Observational
400
Essen
2024-05-08
Active, closed
Pfizer
Observational
360
Freiburg im Breisgau, Kassel, Aachen, Andernach, Berlin, Cologne, Dachau, Frankfurt am Main
2024-05-08
Recruiting
Technical University of Munich
Phase 4
2,252
Munich, Hanover, Dresden
2024-05-08
Recruiting
University of Ulm
Not applicable
80
Ulm
2024-05-08
Recruiting
PSC Partners Seeking a Cure
Observational
2,000
Hamburg
2024-05-06
Recruiting
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
NCT06508775Melanoma Stage III, B-cell Non Hodgkin Lymphoma, Pediatric ALL, Childhood Non-Hodgkin Lymphoma
Miltenyi Biomedicine GmbH
Not applicable
40
Berlin, Cologne, Erlangen, Göttingen, Münster, Tübingen, Würzburg
2024-05-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Heidelberg, Göttingen, Dresden, Kiel, Berlin, Hamburg
2024-05-03
Recruiting
Sensation Seeking and TMS Response in TRD
NCT07889739MDD, Severe Depression, Major Depressive Episode
Technical University of Munich
Observational
100
München
2024-05-02
Active, closed
Hoffmann-La Roche
Phase 2
256
Berlin, München
2024-05-02
By invitation
University of Modena and Reggio Emilia
Observational
500
Munich
2024-05-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
482
Lübeck, Berlin, Bonn, Göttingen, Hamburg, Heidelberg, Leipzig, Mannheim
2024-05-01
Recruiting
Weizmann Institute of Science
Observational
40
Hamburg
2024-05-01
Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
NCT07213531Heart Valve Disease, TAVI, M-TEER, TTVI
Montreal Heart Institute
Observational
21,000
Hamburg, Mainz
2024-05-01
Recruiting
Pancreatitis - Microbiome as Predictor of Severity II
NCT06508502Acute Pancreatitis, Acute Pancreatitis With Infected Necrosis
University Medical Center Goettingen
Observational
700
Göttingen
2024-05-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bad Nauheim, Bad Oeynhausen, Berlin, Bremen, Dortmund, Dresden, Elsterwerda, Essen
2024-04-30
Recruiting
Sven Behrendt
Not applicable
40
Dortmund
2024-04-30
Recruiting
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
NCT04183660Cardiac Failure, Respiratory Failure, Cardio-Respiratory Failure, Imminent Cardiorespiratory or Respiratory Failure
Hemovent GmbH
Observational
60
Hanover, Essen, Halle, Erfurt
2024-04-30
Recruiting
University Hospital Tuebingen
Phase 2
60
Tübingen, Jena
2024-04-29
Active, closed
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Atopic Dermatitis
DrugAPG777
Apogee Therapeutics, Inc.
Phase 2
470
Freiburg im Breisgau, Heidelberg, Tübingen, Augsburg, München, Blankenfelde-Mahlow, Darmstadt, Frankfurt am Main
2024-04-29
Recruiting
Eli Lilly and Company
Phase 3
510
Berlin, Dresden, Frankfurt am Main, Jena, Lübeck, Sachsen
2024-04-29
Recruiting
AstraZeneca
Phase 3
582
Berlin, Cologne, Erfurt, Frankfurt, Göttingen, Immenhausen, Kiel, Mainz
2024-04-29
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
61
Ulm
2024-04-29
Recruiting
CSL Behring
Phase 2/3
3,110
Berlin, Hessen, Kaiserslautern, Kiel, Leipzig, Mainz, Villingen-Schwenningen
2024-04-27
Active, closed
Eli Lilly and Company
Phase 3
450
Berlin, Dresden, Frankfurt am Main, Heidelberg, Marburg, Weisbaden
2024-04-26
Active, closed
Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany
NCT06336330Heart Diseases, Cardiovascular Diseases, Heart Failure
AstraZeneca
Observational
831
Aachen, Alsfeld, Bamberg, Bechhofen, Bergisch Gladbach, Berlin, Brilon, Bruchsal
2024-04-25
Recruiting
BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation
NCT05717192Emphysema or Chronic Obstructive Pulmonary Disease
IHF GmbH - Institut für Herzinfarktforschung
Not applicable
224
Berlin, Bonn, Essen, Halle, Heidelberg, Hemer, Immenhausen, Langen
2024-04-24
Active, closed
Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data
NCT07008729Chronic Heart Failure, Heart Transplant Recipient, Left Ventricular Assist Device
Puerta de Hierro University Hospital
Not applicable
390
Hanover
2024-04-24
Recruiting
CentroDerm GmbH
Not applicable
20
Wuppertal
2024-04-23
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Essen, Leipzig, Stuttgart
2024-04-22
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Düsseldorf, Jena
2024-04-22
Active, closed
Amgen
Phase 3
111
Cologne, Würzburg
2024-04-22
Recruiting
Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial
NCT07137260Pulmonary Hypertension, Precapillary Pulmonary Hypertension, Right Heart Catheterisation, Digital Mobility Outcomes
Simon Jäger
Observational
77
Stuttgart, Munich, Nuremberg, Löwenstein
2024-04-19
Recruiting
Stephanie Gräger
Not applicable
80
Jena
2024-04-19
Recruiting
University Hospital Heidelberg
Phase 2/3
80
Heidelberg
2024-04-19
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Berlin, Braunschweig, Cologne, Dresden, Frankfurt am Main, Hamburg, Herne, Jena
2024-04-18
Recruiting
University of Ulm
Not applicable
150
Ulm
2024-04-17
Recruiting
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
NCT06137378Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III, Laryngeal Squamous Cell Carcinoma Stage IV
University of Leipzig
Phase 2
140
Mannheim, Ulm, München, Regensburg, Würzburg, Potsdam, Cologne, Leipzig
2024-04-17
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Augsburg, Berlin, Dachau, Frankfurt, Göttingen, Halle, Hanover, Kiel
2024-04-17
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
24
Augsburg, Berlin, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg, Hanover, München
2024-04-17
Active, closed
Bristol-Myers Squibb
Phase 3
44
Munich, Berlin
2024-04-17
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Bayreuth, Berlin, Bochum, Dresden, Düsseldorf, Essen, Giessen, Hamburg
2024-04-16
Active, closed
argenx
Phase 3
119
Berlin, Bochum, Würzburg
2024-04-16
Recruiting
Prevalence of Synovitis in Patients With Haemophilia A
NCT06352216Haemophilia A, Synovitis, Hemophilia Arthropathy, Sonography
University Hospital, Bonn
Observational
300
Bonn
2024-04-15
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
Berlin, Cologne, Freiburg im Breisgau, Greifswald, Halle, Kiel, Münster, Stuttgart
2024-04-15
By invitation
Intellia Therapeutics
Observational
100
Berlin
2024-04-12
Active, closed
Celldex Therapeutics
Phase 2
140
Augsburg, Bad Bentheim, Berlin, Bochum, Erlangen, Frankfurt, Heidelberg, Münster
2024-04-12
Active, closed
PROTeIn-rich Meals to Control Glucose
NCT06382480Overweight, Obesity, Prediabetes, Type 2 Diabetes
German Institute of Human Nutrition
Not applicable
30
Potsdam
2024-04-12
Recruiting
AstraZeneca
Phase 3
3,850
Bad Nauheim, Bechhofen, Berlin, Bernau bei Berlin, Chemnitz, Coburg, Dresden, Elsterwerda
2024-04-12
Recruiting
AstraZeneca
Phase 3
675
Berlin, Bonn, Cologne, Düsseldorf, Essen, Freiburg im Breisgau, Gauting, Georgsmarienhütte
2024-04-11
Active, closed
University Hospital Tuebingen
Phase 2
107
Augsburg, Cologne, Frankfurt, Freiburg im Breisgau, Leipzig, Mannheim, Munich, Regensburg
2024-04-10
Recruiting
Daiichi Sankyo
Phase 1/2
680
Heidelberg, Heilbronn, Münster, Mainz, Dresden, Leipzig, Berlin
2024-04-10
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Stuttgart, Munich, Dresden, Jena, Berlin, Hamburg
2024-04-10
Recruiting
Cohort Study on Plant-based Diets (COPLANT Study)
NCT06323538Dietary Exposure, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Bone Loss
German Federal Institute for Risk Assessment
Observational
6,000
Karlsruhe, Jena, Berlin, Bonn, Giessen, Heidelberg, Regensburg
2024-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Cologne, Halle, Leverkusen, Lübeck, Mettmann, München
2024-04-09
Active, closed
Amgen
Phase 3
434
Heidelberg, Bad Doberan, Greifswald Hansestadt, Chemnitz, Hamburg
2024-04-08
Recruiting
Technische Universität Dresden
Phase 2
146
Essen, Aachen, Augsburg, Chemnitz, Cologne, Dresden, Erlangen, Frankfurt am Main
2024-04-07
Recruiting
Marc Bosiers, MD
Observational
109
Berlin, Frankfurt, Göttingen, Heidelberg, Lünen, Münster, Regensburg, Stuttgart
2024-04-05
Active, closed
University of Heidelberg Medical Center
Phase 3
411
Aachen, Augsburg, Bad Saarow, Berlin, Bielefeld, Bonn, Braunschweig, Chemnitz
2024-04-05
Active, closed
Novartis Pharmaceuticals
Phase 2
23
Essen, München
2024-04-04
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
Avalyn Pharma Inc.
Phase 2
398
Munich, München, Rosenheim, Hanover, Frankfurt, Essen, Mainz, Leipzig
2024-04-03
Recruiting
Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression
NCT06396312Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms, Depressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms), Depressive Disorder, Major, Recurrent, With Psychotic Symptoms, Depressive Disorder, Major, Recurrent, Without Psychotic Symptoms
Max-Planck-Institute of Psychiatry
Observational
130
Munich
2024-04-02
Active, closed
Gaia AG
Not applicable
328
Hamburg
2024-04-02
Recruiting
Hoffmann-La Roche
Phase 4
320
Cologne, Essen, Karlsruhe, Mannheim, Ulm
2024-04-02
Recruiting
Prediction of Heart-Failure with Machine Learning
NCT06819618Heart Failure with Reduced Ejection Fraction, Heart Failure, Heart Failure,Congestive, Heart Failure Acute
University Medical Center Goettingen
Observational
32
Goettigen
2024-04-01
By invitation
Return to Activity After Total Knee Arthroplasty
NCT07006545Total Knee Arthroplasty
University Hospital, Bonn
Observational
400
Munich, Bonn
2024-04-01
Active, closed
Novo Nordisk A/S
Phase 3
673
Bremen, Dresden, Elsterwerda, Erfurt, Frankfurt, Freiburg im Breisgau, Fulda, Homburg
2024-04-01
Recruiting
Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data
NCT06317181Artificial Intelligence, Ultrasonography, Elasticity Imaging Techniques, Liver Diseases
Technische Universität Dresden
Not applicable
200
Dresden, Halle, Leipzig
2024-04-01
Recruiting
Central Institute of Mental Health, Mannheim
Not applicable
140
Mannheim
2024-04-01
Recruiting
Seroma of the Mammary Gland
NCT05899387Seroma, Breast Cancer, Mastectomy, Breast Implant; Complications
University Hospital Augsburg
Not applicable
2,000
Augsburg
2024-04-01
Recruiting
University of Bonn
Observational
50
Bonn
2024-04-01
Recruiting
Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
NCT06634121Mitral Regurgitation, Valvular Heart Disease, Heart Failure
LMU Klinikum
Not applicable
180
Munich
2024-04-01
Recruiting
University Hospital Heidelberg
Not applicable
30
Heidelberg
2024-04-01
Not yet open
Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)
NCT05587621ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction, LDL-cholesterol
Jena University Hospital
Not applicable
300
Jena, Berlin, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Halle, Homburg
2024-04-01
Active, closed
Takeda
Phase 2
213
Frankfurt am Main, Hamburg, Heidelberg, Kiel, Ludwigshafen, Tübingen, Ulm
2024-03-29
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
584
Aachen, Berlin, Erlangen, Essen, Greifswald, Hanover, Mainz, München
2024-03-29
Recruiting
Splice Bio
Observational
75
Bonn, Tübingen
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Aachen, Amberg, Bad Oeynhausen, Berlin, Bochum, Dresden, Essen, Falkensee
2024-03-29
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
120
Essen, Magdeburg, Düsseldorf, Erlangen, München
2024-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Munich, Regensburg, Dresden, Halle, Berlin
2024-03-28
Active, closed
Gilead Sciences
Phase 2
228
Dresden, Halle, Kiel, Ulm
2024-03-27
Recruiting
Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2
NCT06025123Out-Of-Hospital Cardiac Arrest, Hypothermia, Ventricular Fibrillation
Karolinska Institutet
Not applicable
1,022
Bamberg, Freiburg im Breisgau, Halle, Kandel
2024-03-27
Recruiting
Negative Emotionality and Epigenetics During Puberty
NCT06690866Puberty, Healthy, Stress
International Research Training Group 2804
Observational
100
Tübingen
2024-03-26
Recruiting
Italfarmaco
Phase 3
220
Mannheim, Dresden, Halle, Hamburg
2024-03-26
Recruiting
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
NCT06163430Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
330
Aachen, Berlin, Frankfurt am Main, Hanover, Jena, Mannheim, München
2024-03-26
Recruiting
University Hospital Goettingen
Phase 3
102
Heidelberg, München, Hamburg, Frankfurt am Main, Göttingen, Cologne, Münster, Leipzig
2024-03-25
Active, closed
Gilead Sciences
Phase 3
577
Aachen, Berlin, Cologne, Frankfurt, Hamburg, Munich, München
2024-03-25
Active, closed
AbbVie
Phase 2
156
Ulm, Munich, Ludwigshafen am Rhein, Leipzig, Kiel, Hamburg
2024-03-23
Recruiting
Molecure S.A.
Phase 2
96
Essen, Freiburg im Breisgau, Mainz-GE
2024-03-21
Recruiting
GlaxoSmithKline
Phase 3
864
Augsburg, Berlin, Erlangen, Essen, Giessen, Hamburg, Neuruppin, Straubing
2024-03-21
Active, closed
GlaxoSmithKline
Phase 4
336
Aachen, Bonn, Darmstadt, Frankfurt, Hohenstein-Ernsttal, Schleswig
2024-03-20
Recruiting
Charite University, Berlin, Germany
Not applicable
140
Berlin
2024-03-20
Recruiting
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
NCT06024109Abnormal Uterine Bleeding, Endometriosis, Uterine Prolapse, Uterine Cancer
Aesculap AG
Observational
132
Frankfurt am Main
2024-03-19
Recruiting
Verastem, Inc.
Phase 3
270
Frankfurt am Main, Berlin, Dresden, Essen, Hamburg, Mannheim, Ulm
2024-03-18
Active, closed
University of Ulm
Not applicable
31
Ulm
2024-03-18
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Bochum, Cologne, Erlangen, Essen, Heidelberg, Leipzig, Munich, Regensburg
2024-03-15
By invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
NCT05932615Aortic Valve Stenosis, Heart Valve Diseases, Aortic Valve Disease, Heart Disease Structural Disorder
Abbott Medical Devices
Not applicable
1,500
Dortmund, Bad Nauheim, Cologne, Frankfurt, Kiel, München, Ulm
2024-03-15
Recruiting
AstraZeneca
Phase 3
100
Berlin, Freiburg im Breisgau, Sankt Augustin
2024-03-14
Recruiting
Technische Universität Dresden
Observational
500
Aachen, Chemnitz, Dresden, Düsseldorf, Essen, Göttingen, Hamburg, Jena
2024-03-13
Recruiting
WALA Heilmittel GmbH
Phase 3
350
Mannheim
2024-03-13
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Hoffmann-La Roche
Phase 3
1,350
Chemnitz, Frankfurt am Main, Freiburg im Breisgau, Hanover, Homburg, Münster
2024-03-13
Recruiting
Medical University Innsbruck
Not applicable
1,350
Essen, Freiburg im Breisgau, Giessen, Jena
2024-03-12
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Düsseldorf, Halle, Moers, Neuss
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Munich, Cologne, Aachen, Augsburg, Berlin, Essen, Münster, Rostock
2024-03-12
Recruiting
Lohmann & Rauscher
Observational
208
Aachen, Brüggen, Dortmund, Erlangen, Hamburg, Mönchengladbach, Waidhaus, Willich
2024-03-11
Recruiting
The NEU-STIM Trial
NCT05942924Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Dresden, Düsseldorf, Tübingen
2024-03-11
Active, closed
Edward Geissler
Phase 4
322
Aachen, Berlin, Bochum, Dresden, Hamburg, Hanover, Jena, Mainz
2024-03-09
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Augsburg, Bad Bentheim, Berlin, Bochum, Darmstadt, Dresden, Dülmen, Düsseldorf
2024-03-09
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Frankfurt am Main, Kaiserslautern, Dresden, Leipzig, Ahaus, Berlin, Bonn, Essen
2024-03-07
Recruiting
Universität Duisburg-Essen
Not applicable
118
Bamberg
2024-03-06
Recruiting
University of Cologne
Phase 2
29
Cologne
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aachen, Bad Friedrichshall, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2024-03-05
Active, closed
Real World Use of Tocilizumab Biosimilar studY
NCT06247722Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH
Observational
600
Berlin, Halle, Ludwigsfelde, Magdeburg, Naumburg, Planegg, Potsdam, Templin
2024-03-05
Recruiting
Takeda
Phase 2
268
Frankfurt, Frankfurt am Main, Kiel, Ludwigshafen, Mannheim, Tübingen, Ulm
2024-03-05
Recruiting
PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
NCT06320223Prostate Cancer, PET/CT, Survivorship, PSMA
University Hospital, Essen
Observational
10,000
Essen
2024-03-05
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Munich, Ulm
2024-03-04
Active, closed
AstraZeneca
Phase 3
594
Berlin, Frankfurt, Göttingen, Hamburg, Heidelberg, Heilbronn, Leipzig, Marburg
2024-03-04
Recruiting
Catholic University of Applied Sciences Mainz
Not applicable
150
Bad Kreuznach, Meisenheim
2024-03-04
Recruiting
Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis
NCT06556407Treatment Resistant Hypertension, Chronic Hemodialysis
University of Erlangen-Nürnberg Medical School
Not applicable
12
Erlangen
2024-03-04
Recruiting
Assessing Habitual, Goal-Directed, and Pavlovian Influences in Alcohol Use Disorder
NCT06701500Alcohol Use Disorder (AUD), Alcoholism, Substance Use Disorders
Technische Universität Dresden
Observational
180
Dresden
2024-03-02
Not yet open
Universitätsklinikum Hamburg-Eppendorf
Observational
148
Hamburg
2024-03-01
Active, closed
Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning
NCT05471882Residual Paralysis, Post Anesthesia, Postoperative Complications, Neuromuscular Blockade, Quantitative Neuromuscular Monitoring
University Hospital Ulm
Observational
240,000
Ulm, Munich
2024-03-01
Recruiting
Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT06834152Localized Prostate Carcinoma, Prostate Cancer (Adenocarcinoma), Prostate Hyperplasia, Lower Urinary Track Symptoms
University of Zurich
Observational
75
Heidelberg, Munich
2024-03-01
Recruiting
Takeda
Phase 3
50
Aachen, Berlin, Hanover, Tübingen
2024-03-01
Recruiting
Predicting Esophageal Cancer Borders Using PET-Imaging
NCT06408116Esophagus Cancer, Stage I, Esophagus Cancer, Stage II
University Hospital Heidelberg
Phase 2
30
Heidelberg
2024-03-01
Recruiting
University Hospital Muenster
Observational
2,000
Chemnitz, Aachen, Greifswald, Leipzig, Münster, Tübingen
2024-03-01
By invitation
Christian Dorfer
Observational
100
Berlin, Tübingen
2024-03-01
Recruiting
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
NCT06280755Multiple Sclerosis, NMO Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Radiologically Isolated Syndrome
icometrix
Observational
7,000
Bochum, Berlin
2024-03-01
Recruiting
Amsterdam UMC
Not applicable
654
Mainz
2024-03-01
Recruiting
Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption
NCT06247306Alcohol Abuse, Craving, Psychosocial Stressor, Neural Stress Response
Central Institute of Mental Health, Mannheim
Not applicable
102
Mannheim
2024-03-01
Active, closed
Safety and Performance of the Biphasic Plate Distal Femur: A Multicenter Case Series
NCT06028971Distal Femur Fracture, Periprosthetic Fractures, Intra-Articular Fractures, Supracondylar Fracture
41medical AG
Observational
60
Münster, Siegen
2024-02-29
Recruiting
University of Bonn
Observational
50
Bonn
2024-02-29
Recruiting
University of Erlangen-Nürnberg Medical School
Not applicable
148
Erlangen
2024-02-29
Active, closed
Acumen Pharmaceuticals
Phase 2
542
Berlin, Cologne, Mannheim, Munich
2024-02-29
Recruiting
Heidelberg University
Not applicable
304
Berlin, Düsseldorf, Heidelberg, Jena, Ulm
2024-02-28
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Freiburg im Breisgau, Munich, Regensburg, Weiden in Der Oberpfalz, Langen, Bergisch Gladbach, Essen, Mönchengladbach
2024-02-28
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Essen, Kiel
2024-02-28
Recruiting
Daiichi Sankyo
Phase 2/3
860
Dresden, Essen, Hamburg, Mannheim, Ulm
2024-02-27
Active, closed
Terumo Europe N.V.
Not applicable
50
Heilbronn, Tübingen
2024-02-27
Recruiting
Heidelberg University
Not applicable
60
Heidelberg
2024-02-27
Recruiting
Larry Hinkson
Not applicable
356
Berlin
2024-02-27
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Frankfurt
2024-02-26
Recruiting
Aleksander Krag
Phase 3
240
Berlin, Jena, Münster
2024-02-26
Recruiting
Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures
NCT06289699User Experience, Postoperative Complications, Acute Medical Conditions
Christian S. Meyhoff
Observational
100
Hamburg
2024-02-26
Recruiting
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
NCT06208007Heart Failure With Preserved Ejection Fraction, Cardiovascular Morbidity
University Medical Center Goettingen
Observational
150
Göttingen
2024-02-23
Recruiting
Pulmonx Corporation
Not applicable
200
Essen, Halle, Hamburg, Heidelberg, Hemer
2024-02-22
Recruiting
Electrosurgical Intervention Analysis: Comparing Procedure Patterns
NCT06873347Surgical Procedure, Unspecified
University Hospital Tuebingen
Observational
160
Tübingen
2024-02-21
Recruiting
Intraocular Lens Implant Registry Study
NCT06294405Intraocular Lens Complication, Intraocular Lens Rotation, Intraocular Lens Associated Postoperative Inflammation, Lens Opacities
University Hospital Augsburg
Observational
500
Augsburg
2024-02-21
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Halle, Bonn, Esslingen am Neckar, Frankfurt a.M., Gauting, Großhansdorf, Heidelberg
2024-02-21
Recruiting
AI-Based Real-Time Detection of Surgical Smoke Using Endoscopic Data
NCT07397000Detection of Surgical Smoke Gas Using AI
University Hospital Tuebingen
Observational
30
Tübingen
2024-02-21
Recruiting
AstraZeneca
Phase 3
5,250
Ahrensburg, Augsburg, Bamberg, Berlin, Bonn, Bremen, Cottbus, Dachau
2024-02-21
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
47
München
2024-02-20
Recruiting
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
NCT06134492Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia, Herpes Simplex
Jena University Hospital
Phase 3
616
Freiburg im Breisgau, Heidelberg, Tübingen, Augsburg, München, Nuremberg, Regensburg, Rosenheim
2024-02-20
Active, closed
Novo Nordisk A/S
Phase 2
88
Heidelberg, München, Münster, Würzburg
2024-02-20
Rows per page Showing 2001–2500 of 5062
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-germany?page=5

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Germany?

2,869 of the 5,062 studies in this register are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 254 have not yet opened recruitment, 1,794 are active but closed to new participants, and 145 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (81) Multiple Myeloma (70) Heart Failure (69) Obesity (56) Coronary Artery Disease (42) Prostate Cancer (42) Atrial Fibrillation (41) Non-small Cell Lung Cancer (36) Carcinoma, Non-Small-Cell Lung (34) Non-Small Cell Lung Cancer (33) Ulcerative Colitis (33) Cancer (31) Multiple Sclerosis (31) Overweight (29) Atopic Dermatitis (29)
→

Browse trials by site location

Berlin (1587) Hamburg (893) Essen (765) Dresden (714) Heidelberg (626) Cologne (619) Leipzig (513) München (510) Hanover (487) Tübingen (454) Bonn (422) Düsseldorf (409) Munich (398) Freiburg im Breisgau (394) Erlangen (374)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.